DE280853C
(pt)
|
|
|
|
|
US850370A
(en)
|
1906-06-05 |
1907-04-16 |
William L Hynes |
Water-automobile.
|
DE2156720A1
(de)
|
1971-11-16 |
1973-05-24 |
Bayer Ag |
Pyrimido eckige klammer auf 4,5-d eckige klammer zu pyrimidine
|
US3894021A
(en)
|
1974-01-28 |
1975-07-08 |
Squibb & Sons Inc |
Derivatives of 1,7-dihydro-2H-pyrazolo{8 4{40 ,3{40 :5,6{9 pyrido{8 4,3-D{9 pyrimidine-2,4-(3H)-diones
|
JPS5120580B2
(pt)
|
1974-06-19 |
1976-06-25 |
|
|
US4347348A
(en)
|
1978-06-05 |
1982-08-31 |
Chernikhov Alexei Y |
Heat-resistant heterocyclic polymers and methods for producing same
|
FR2428654A1
(fr)
|
1978-06-13 |
1980-01-11 |
Chernikhov Alexei |
Polymeres heterocycliques thermostables et leurs procedes de preparation
|
CH641470A5
(de)
|
1978-08-30 |
1984-02-29 |
Ciba Geigy Ag |
Imidgruppen enthaltende silane.
|
CH635828A5
(de)
|
1978-08-30 |
1983-04-29 |
Ciba Geigy Ag |
N-substituierte imide und bisimide.
|
US4339267A
(en)
|
1980-01-18 |
1982-07-13 |
E. I. Du Pont De Nemours And Company |
Herbicidal sulfonamides
|
US4405786A
(en)
|
1980-10-22 |
1983-09-20 |
Plastics Engineering Company |
Addition products of di-acetylene-terminated polyimide derivatives and an dienophile having ethylene groups
|
US4402878A
(en)
|
1980-10-22 |
1983-09-06 |
Plastics Engineering Company |
Addition products of di-acetylene-terminated polyimide derivatives with a polyimide having terminal non-conjugated acetylene groups
|
US4405519A
(en)
|
1980-10-22 |
1983-09-20 |
Plastics Engineering Company |
Di-Acetylene-terminated polyimide derivatives
|
US4405520A
(en)
|
1980-10-22 |
1983-09-20 |
Plastics Engineering Company |
Addition products of di-acetylene-terminated polymide derivatives and dienophiles having terminal maleimide grops
|
US4460773A
(en)
|
1982-02-05 |
1984-07-17 |
Lion Corporation |
1-Phenyl-1H-pyrazolo [3,4-b]pyrazine derivatives and process for preparing same
|
DE3432983A1
(de)
|
1983-09-07 |
1985-04-18 |
Lion Corp., Tokio/Tokyo |
1,5-disubstituierte 1h-pyrazolo(3,4-b)-pyrazin-derivate und antitumormittel, die diese enthalten
|
JPS62273979A
(ja)
|
1986-05-21 |
1987-11-28 |
Lion Corp |
1,5−置換−1H−ピラゾロ〔3,4−b〕ピラジン誘導体及び該化合物を含有する抗腫瘍剤
|
JPS6310630A
(ja)
|
1986-06-23 |
1988-01-18 |
Teijin Ltd |
芳香族ポリアミドイミドエ−テルの製造法
|
JPS6317882A
(ja)
|
1986-07-09 |
1988-01-25 |
Lion Corp |
5−置換−1H−ピラゾロ〔3,4−b〕ピラジン誘導体及び該化合物を含有する抗腫瘍剤
|
US4859672A
(en)
|
1986-10-29 |
1989-08-22 |
Rorer Pharmaceutical Corporation |
Pyrido[2,3-d]pyrimidinone and imidazo[4,5-b]pyrimidinone
|
US4874803A
(en)
|
1987-09-21 |
1989-10-17 |
Pennwalt Corporation |
Dianhydride coupled polymer stabilizers
|
DE3814549A1
(de)
|
1987-10-30 |
1989-05-18 |
Bayer Ag |
N-substituierte derivate von 1-desoxynojirimycin und 1-desoxymannonojirimycin, verfahren zu deren herstellung und deren verwendung in arzneimitteln
|
JPH029895A
(ja)
|
1988-06-28 |
1990-01-12 |
Lion Corp |
ヌクレオシド類似化合物及び抗腫瘍剤
|
US5159054A
(en)
|
1989-05-16 |
1992-10-27 |
The United States Of America As Represented By The Secretary Of The Navy |
Synthesis of phthalonitrile resins containing ether and imide linkages
|
JP2845957B2
(ja)
|
1989-07-17 |
1999-01-13 |
三井化学株式会社 |
イミド環を有する新規ジフェノール類およびその製造方法
|
US5726302A
(en)
|
1989-09-15 |
1998-03-10 |
Gensia Inc. |
Water soluble adenosine kinase inhibitors
|
DE3937633A1
(de)
|
1989-11-11 |
1991-05-16 |
Bayer Ag |
Heterocyclische verbindungen und deren verwendung als pigmente und farbstoffe
|
EP0507824B1
(de)
|
1989-12-28 |
1994-10-19 |
Hoechst Aktiengesellschaft |
Biskationische säureamid- und -imidderivate und verfahren zu ihrer herstellung
|
WO1991010172A1
(de)
|
1989-12-28 |
1991-07-11 |
Hoechst Aktiengesellschaft |
Biskationische säureamid- und -imidderivate als ladungssteuermittel
|
JP2883670B2
(ja)
|
1990-03-23 |
1999-04-19 |
三井化学株式会社 |
イミド環を有する新規ビスフェノール類およびその製造方法
|
GB9113137D0
(en)
|
1990-07-13 |
1991-08-07 |
Ici Plc |
Thioxo heterocycles
|
NZ240089A
(en)
|
1990-10-03 |
1993-04-28 |
Commw Scient Ind Res Org |
Diaminobisimide compounds and compositions comprising such compounds for curing epoxy resins
|
JPH04158084A
(ja)
|
1990-10-22 |
1992-06-01 |
Fuji Photo Film Co Ltd |
記録材料
|
JPH04179576A
(ja)
|
1990-11-14 |
1992-06-26 |
Fuji Photo Film Co Ltd |
記録材料
|
JPH04328121A
(ja)
|
1991-04-26 |
1992-11-17 |
Sumitomo Bakelite Co Ltd |
半導体封止用エポキシ樹脂組成物
|
WO1992022552A1
(en)
|
1991-06-14 |
1992-12-23 |
The Upjohn Company |
IMIDAZO[1,5-a]QUINOXALINES
|
DE4119767A1
(de)
|
1991-06-15 |
1992-12-17 |
Dresden Arzneimittel |
Verfahren zur herstellung von (pyrimid-2-yl-thio- bzw. seleno)-essigsaeurederivaten
|
US5521184A
(en)
|
1992-04-03 |
1996-05-28 |
Ciba-Geigy Corporation |
Pyrimidine derivatives and processes for the preparation thereof
|
JP3279635B2
(ja)
|
1992-05-18 |
2002-04-30 |
鐘淵化学工業株式会社 |
ヒドロシリル基含有イミド化合物
|
JP3232123B2
(ja)
|
1992-05-20 |
2001-11-26 |
鐘淵化学工業株式会社 |
硬化性組成物
|
EP0642510A4
(en)
|
1992-05-28 |
1997-04-02 |
Commw Scient Ind Res Org |
BISMALEIMIDE COMPOUNDS.
|
NZ258488A
(en)
|
1992-12-07 |
1997-02-24 |
Commw Scient Ind Res Org |
Preparation of bisnadimides (n,n'-bis(aryl)aryl diimides) from an n,n'-bis (aminoaryl)aryldiimide and nadic acid; curable compositions and fibre reinforced cured composites
|
WO1994015995A1
(en)
|
1993-01-11 |
1994-07-21 |
The Trustees Of The University Of Pennsylvania |
Polycyclic aromatic compounds having nonlinear optical properties
|
WO1994025438A1
(en)
|
1993-04-28 |
1994-11-10 |
The Du Pont Merck Pharmaceutical Company |
Novel trisubstituted aromatic amines useful for the treatment of cognitive deficits
|
US5536725A
(en)
|
1993-08-25 |
1996-07-16 |
Fmc Corporation |
Insecticidal substituted-2,4-diamino-5,6,7,8-tetrahydroquinazolines
|
DK0731795T3
(da)
|
1993-11-30 |
2000-05-15 |
Searle & Co |
Substituerede pyrazolylbenzensulfonamider til behandling af inflammation
|
US5480887A
(en)
|
1994-02-02 |
1996-01-02 |
Eli Lilly And Company |
Protease inhibitors
|
ES2153434T3
(es)
|
1994-02-02 |
2001-03-01 |
Lilly Co Eli |
Inhibidores de la proteasa del vih y sus intermedios.
|
TJ342B
(en)
|
1994-11-14 |
2002-10-06 |
Warner Lambert Co |
Derivatives of 6-aryl pyrido Ä2,3-dÜ pyrimidines and naphthyridines pharmaceutical composition possess inhibiting effect of cellular proliferation pr ovoking protein tyrosine kinase and method of inhibiting cellular proliferation
|
US7067664B1
(en)
|
1995-06-06 |
2006-06-27 |
Pfizer Inc. |
Corticotropin releasing factor antagonists
|
US5783577A
(en)
|
1995-09-15 |
1998-07-21 |
Trega Biosciences, Inc. |
Synthesis of quinazolinone libraries and derivatives thereof
|
JPH09188812A
(ja)
|
1996-01-11 |
1997-07-22 |
Mitsui Toatsu Chem Inc |
結晶化促進剤
|
AU2980797A
(en)
|
1996-06-11 |
1998-01-07 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Fused heterocyclic compounds and medicinal uses thereof
|
DK0920429T3
(da)
|
1996-08-06 |
2003-05-12 |
Pfizer |
Substituerede pyrido- eller pyrimidoholdige, 6,6- eller 6,7-bicykliske derivater
|
WO1998006703A1
(en)
|
1996-08-14 |
1998-02-19 |
Warner-Lambert Company |
2-phenyl benzimidazole derivatives as mcp-1 antagonists
|
JP3669783B2
(ja)
|
1996-08-21 |
2005-07-13 |
三井化学株式会社 |
有機電界発光素子
|
US5994364A
(en)
|
1996-09-13 |
1999-11-30 |
Schering Corporation |
Tricyclic antitumor farnesyl protein transferase inhibitors
|
WO1998018781A2
(en)
|
1996-10-28 |
1998-05-07 |
Versicor, Inc. |
Fused 2,4-pyrimidinedione combinatorial libraries, their preparation and the use of fused 2,4-pyrimidinediones derivatives as antimicrobial agents
|
WO1998028281A1
(en)
|
1996-12-23 |
1998-07-02 |
Celltech Therapeutics Limited |
Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
|
BR9807305A
(pt)
|
1997-02-05 |
2000-05-02 |
Warner Lambert Co |
Pirido [2,3-d] pirimidinas e 4-aminopirimidinas como inibidores de proliferação celular.
|
CA2285263C
(en)
|
1997-04-11 |
2009-03-10 |
Abbott Laboratories |
Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission
|
ATE286886T1
(de)
|
1997-05-28 |
2005-01-15 |
Aventis Pharma Inc |
Chinolin- und chinoxalin-verbindungen die den von blutplättchen abstammmenden wachstumsfaktor und/oder pdgf- und p56lck-tyrosin-kinase hemmen
|
GB9716231D0
(en)
|
1997-07-31 |
1997-10-08 |
Amersham Int Ltd |
Base analogues
|
JP2001512742A
(ja)
|
1997-08-11 |
2001-08-28 |
シーオーアール セラピューティクス インコーポレイテッド |
選択的Xa因子阻害剤
|
ATE286053T1
(de)
|
1997-08-20 |
2005-01-15 |
Warner Lambert Co |
Naphthyridinone zur hemmung der durch protein- tyrosin-kinase und zellzyklus kinase hervorgerufenen zellvermehrung
|
US6465484B1
(en)
|
1997-09-26 |
2002-10-15 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
JPH11171865A
(ja)
|
1997-12-04 |
1999-06-29 |
Yoshitomi Pharmaceut Ind Ltd |
縮合ヘテロ環化合物
|
CN1290249A
(zh)
|
1998-02-20 |
2001-04-04 |
武田药品工业株式会社 |
氨基胍腙衍生物、制法及制剂
|
WO1999059975A1
(en)
|
1998-05-15 |
1999-11-25 |
Guilford Pharmaceuticals Inc. |
Fused tricyclic compounds which inhibit parp activity
|
NZ508268A
(en)
|
1998-05-26 |
2004-02-27 |
Warner Lambert Co |
Bicyclic pyrimidines and bicyclic 3,4- dihydropyrimidines as inhibitors of cellular proliferation
|
US20040044012A1
(en)
|
1998-05-26 |
2004-03-04 |
Dobrusin Ellen Myra |
Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
|
EP1086085A1
(en)
|
1998-06-12 |
2001-03-28 |
Vertex Pharmaceuticals Incorporated |
INHIBITORS OF p38
|
PT1107964E
(pt)
|
1998-08-11 |
2010-06-11 |
Novartis Ag |
Derivados de isoquinolina com actividade inibidora da angiogénese
|
JP2000123973A
(ja)
|
1998-10-09 |
2000-04-28 |
Canon Inc |
有機発光素子
|
PL347432A1
(en)
|
1998-10-23 |
2002-04-08 |
Hoffmann La Roche |
Bicyclic nitrogen heterocycles
|
GB9823103D0
(en)
|
1998-10-23 |
1998-12-16 |
Pfizer Ltd |
Pharmaceutically active compounds
|
US6133031A
(en)
|
1999-08-19 |
2000-10-17 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of focal adhesion kinase expression
|
GB9905075D0
(en)
|
1999-03-06 |
1999-04-28 |
Zeneca Ltd |
Chemical compounds
|
DE19912638A1
(de)
|
1999-03-20 |
2000-09-21 |
Bayer Ag |
Naphthylcarbonsäureamid-substituierte Sulfonamide
|
DE19920790A1
(de)
|
1999-05-06 |
2000-11-09 |
Bayer Ag |
Bis-Sulfonamide mit anti-HCMV-Wirkung
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
JP4041624B2
(ja)
|
1999-07-21 |
2008-01-30 |
三井化学株式会社 |
有機電界発光素子
|
MXPA02003182A
(es)
|
1999-09-24 |
2002-09-30 |
Janssen Pharmaceutica Nv |
Composiciones antivirales.
|
DE19946289A1
(de)
|
1999-09-28 |
2001-03-29 |
Basf Ag |
Benzodiazepin-Derivate, deren Herstellung und Anwendung
|
AU776695B2
(en)
|
1999-10-21 |
2004-09-16 |
F. Hoffmann-La Roche Ag |
Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase
|
IL149100A0
(en)
|
1999-10-21 |
2002-11-10 |
Hoffmann La Roche |
Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase
|
TWI271406B
(en)
|
1999-12-13 |
2007-01-21 |
Eisai Co Ltd |
Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same
|
WO2001047892A1
(en)
|
1999-12-29 |
2001-07-05 |
Wyeth |
Tricyclic protein kinase inhibitors
|
KR20020067701A
(ko)
|
2000-01-24 |
2002-08-23 |
워너-램버트 캄파니 |
3-아미노퀴나졸린-2,4-디온 항균제
|
EP1255755A1
(en)
|
2000-01-27 |
2002-11-13 |
Warner-Lambert Company |
Pyridopyrimidinone derivatives for treatment of neurodegenerative disease
|
EP1257551B1
(de)
|
2000-02-01 |
2007-09-05 |
Abbott GmbH & Co. KG |
Heterozyklische verbindungen und deren anwendung als parp-inhibitoren
|
ATE309999T1
(de)
|
2000-02-04 |
2005-12-15 |
Portola Pharm Inc |
Blutplättchen-adp-rezeptor-inhibitoren
|
ATE295365T1
(de)
|
2000-02-09 |
2005-05-15 |
Novartis Pharma Gmbh |
Pyridinderivative als angiogenese- und/oder vegf- rezeptor-tyrosinkinase-inhibitoren
|
GB0004890D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
US7498335B2
(en)
|
2000-03-06 |
2009-03-03 |
Astrazeneca Ab |
Method of producing an antiangiogenic or vascular permeability reducing effect
|
JP2001265031A
(ja)
|
2000-03-15 |
2001-09-28 |
Fuji Xerox Co Ltd |
電子写真感光体、プロセスカートリッジ、及び、電子写真装置
|
DE10012549A1
(de)
|
2000-03-15 |
2001-09-20 |
Bayer Ag |
Arzneimittel gegen virale Erkrankungen
|
KR100901221B1
(ko)
|
2000-04-28 |
2009-06-08 |
아카디아 파마슈티칼스 인코포레이티드 |
무스카린성 작용제
|
EP1278744A1
(en)
|
2000-05-05 |
2003-01-29 |
Millenium Pharmaceuticals, Inc. |
Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors
|
MXPA02012895A
(es)
|
2000-06-23 |
2003-05-14 |
Bristol Myers Squibb Pharma Co |
Derivados de pirazol condensado con 1-(heteroaril-fenil) como inhibidores del factor xa.
|
AU1560802A
(en)
|
2000-06-28 |
2002-01-08 |
Smithkline Beecham Plc |
Wet milling process
|
US20050009876A1
(en)
|
2000-07-31 |
2005-01-13 |
Bhagwat Shripad S. |
Indazole compounds, compositions thereof and methods of treatment therewith
|
IL154310A0
(en)
|
2000-08-07 |
2003-09-17 |
Neurogen Corp |
Heterocyclic compounds as ligands of the gabaa receptor
|
JP5049447B2
(ja)
|
2000-08-14 |
2012-10-17 |
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド |
置換ピラゾール
|
CZ2003635A3
(cs)
|
2000-09-06 |
2004-12-15 |
Ortho Mcneil Pharmaceutical, Inc. |
Substituovaný pyrazol a jeho použití
|
GB0025782D0
(en)
|
2000-10-20 |
2000-12-06 |
Pfizer Ltd |
Use of inhibitors
|
EP1217000A1
(en)
|
2000-12-23 |
2002-06-26 |
Aventis Pharma Deutschland GmbH |
Inhibitors of factor Xa and factor VIIa
|
GB0100621D0
(en)
|
2001-01-10 |
2001-02-21 |
Vernalis Res Ltd |
Chemical compounds VI
|
GB0103926D0
(en)
|
2001-02-17 |
2001-04-04 |
Astrazeneca Ab |
Chemical compounds
|
WO2002076953A1
(en)
|
2001-03-21 |
2002-10-03 |
Warner-Lambert Company Llc |
New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
|
US6998408B2
(en)
|
2001-03-23 |
2006-02-14 |
Bristol-Myers Squibb Pharma Company |
6-5, 6-6, or 6-7 Heterobicycles as factor Xa inhibitors
|
JP2002296731A
(ja)
|
2001-03-30 |
2002-10-09 |
Fuji Photo Film Co Ltd |
熱現像カラー画像記録材料
|
KR20040007497A
(ko)
|
2001-04-16 |
2004-01-24 |
에자이 가부시키가이샤 |
신규 1h-인다졸 화합물
|
EP1382603B1
(en)
|
2001-04-26 |
2008-07-23 |
Eisai R&D Management Co., Ltd. |
Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof
|
ATE386727T1
(de)
|
2001-04-30 |
2008-03-15 |
Glaxo Group Ltd |
Kondensierte pyrimidine als antagonisten des corticotropin releasing factor (crf)
|
WO2002094825A1
(fr)
|
2001-05-22 |
2002-11-28 |
Banyu Pharmaceutical Co., Ltd. |
Nouveau derive de spiropiperidine
|
US20030114448A1
(en)
|
2001-05-31 |
2003-06-19 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of factor Xa
|
AU2002302894A1
(en)
|
2001-06-19 |
2003-01-02 |
Warner-Lambert Company Llc |
Quinazolinediones as antibacterial agents
|
AU2002315389A1
(en)
|
2001-06-21 |
2003-01-08 |
Ariad Pharmaceuticals, Inc. |
Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
WO2003000690A1
(en)
|
2001-06-25 |
2003-01-03 |
Aventis Pharmaceuticals Inc. |
Synthesis of heterocyclic compounds employing microwave technology
|
US20040235867A1
(en)
|
2001-07-24 |
2004-11-25 |
Bilodeau Mark T. |
Tyrosine kinase inhibitors
|
PL367983A1
(en)
|
2001-08-07 |
2005-03-21 |
Banyu Pharmaceutical Co, Ltd. |
Spiro compounds
|
ATE420879T1
(de)
|
2001-09-19 |
2009-01-15 |
Aventis Pharma Sa |
Indolizine als kinaseproteinhemmer
|
PL211461B1
(pl)
|
2001-10-30 |
2012-05-31 |
Dana Farber Cancer Inst Inc |
Zastosowanie pochodnych staurosporyny do wytwarzania kompozycji farmaceutycznej do leczenia lub zapobiegania białaczkom i zespołom mielodysplastycznym, preparat farmaceutyczny do leczenia białaczek i zestaw farmaceutyczny
|
NZ531853A
(en)
|
2001-11-01 |
2006-02-24 |
Janssen Pharmaceutica Nv |
Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
|
EP1444223A1
(en)
|
2001-11-07 |
2004-08-11 |
F. Hoffmann-La Roche Ag |
Aminopyrimidines and -pyridines
|
EP1456652A4
(en)
|
2001-11-13 |
2005-11-02 |
Dana Farber Cancer Inst Inc |
IMMUNOCELL ACTIVATION MODULATING SUBSTANCES AND USE METHOD THEREFOR
|
GB0129476D0
(en)
|
2001-12-10 |
2002-01-30 |
Syngenta Participations Ag |
Organic compounds
|
GEP20063909B
(en)
|
2002-01-22 |
2006-08-25 |
Warner Lambert Co |
2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d] PYRIMIDIN-7-ONES
|
DK1482924T3
(da)
|
2002-03-05 |
2008-09-29 |
Merck Frosst Canada Ltd |
Cathepsin-cystein-protease-inhibotorer
|
US6815519B2
(en)
|
2002-03-22 |
2004-11-09 |
Chung-Shan Institute Of Science & Technology |
Acidic fluorine-containing poly (siloxane amideimide) silica hybrids
|
EP1492790A1
(en)
|
2002-04-03 |
2005-01-05 |
F. Hoffmann-La Roche Ag |
Imidazo fused compounds
|
RS98804A
(en)
|
2002-05-15 |
2006-10-27 |
Janssen Pharmaceutica N.V. |
N-substituted tricyclic 3-aminopyrazoles as pdfg receptor ihhibitors
|
JP4499342B2
(ja)
|
2002-05-16 |
2010-07-07 |
株式会社カネカ |
SiH基を含有する含窒素有機系化合物の製造方法
|
US7858631B2
(en)
|
2002-05-23 |
2010-12-28 |
Novartis Vaccines And Diagnostics, Inc. |
Substituted pyrido [2,3-d] pyrimidinone compounds
|
TW200406374A
(en)
|
2002-05-29 |
2004-05-01 |
Novartis Ag |
Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
|
US7119111B2
(en)
|
2002-05-29 |
2006-10-10 |
Amgen, Inc. |
2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use
|
US7105526B2
(en)
|
2002-06-28 |
2006-09-12 |
Banyu Pharmaceuticals Co., Ltd. |
Benzimidazole derivatives
|
GB0215676D0
(en)
|
2002-07-05 |
2002-08-14 |
Novartis Ag |
Organic compounds
|
US7196090B2
(en)
|
2002-07-25 |
2007-03-27 |
Warner-Lambert Company |
Kinase inhibitors
|
NZ537752A
(en)
|
2002-07-29 |
2006-12-22 |
Rigel Pharmaceuticals Inc |
Use of 2,4-pyrimidinediamine compounds in the preparation of medicaments for treating autoimmune diseases
|
CN100432073C
(zh)
|
2002-08-06 |
2008-11-12 |
霍夫曼-拉罗奇有限公司 |
作为p-38map激酶抑制剂的6-烷氧基-吡啶并-嘧啶
|
EP1388541A1
(en)
|
2002-08-09 |
2004-02-11 |
Centre National De La Recherche Scientifique (Cnrs) |
Pyrrolopyrazines as kinase inhibitors
|
US7084270B2
(en)
|
2002-08-14 |
2006-08-01 |
Hoffman-La Roche Inc. |
Pyrimido compounds having antiproliferative activity
|
GB0220187D0
(en)
|
2002-08-30 |
2002-10-09 |
Novartis Ag |
Organic compounds
|
GB0223349D0
(en)
|
2002-10-08 |
2002-11-13 |
Merck Sharp & Dohme |
Therapeutic agents
|
US7112676B2
(en)
|
2002-11-04 |
2006-09-26 |
Hoffmann-La Roche Inc. |
Pyrimido compounds having antiproliferative activity
|
TW200413381A
(en)
|
2002-11-04 |
2004-08-01 |
Hoffmann La Roche |
Novel amino-substituted dihydropyrimido [4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents
|
AU2003291310A1
(en)
|
2002-11-06 |
2004-06-03 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds and use thereof
|
AR042052A1
(es)
|
2002-11-15 |
2005-06-08 |
Vertex Pharma |
Diaminotriazoles utiles como inhibidores de proteinquinasas
|
WO2004046152A1
(en)
|
2002-11-18 |
2004-06-03 |
F. Hoffmann La Roche Ag |
Diazinopyrimidines
|
RS20050363A
(en)
|
2002-11-28 |
2007-11-15 |
Schering Aktiengesellschaft, |
Chk-,pdk-and akt-inhibitory pyrimidines,their production an use as pharmaceutical agents
|
ATE443699T1
(de)
|
2002-12-06 |
2009-10-15 |
Purdue Research Foundation |
Pyridine zur behandlung von verletztemsäugetiernervengewebe
|
US7759336B2
(en)
|
2002-12-10 |
2010-07-20 |
Ono Pharmaceutical Co., Ltd. |
Nitrogen-containing heterocyclic compounds and medicinal use thereof
|
UA80171C2
(en)
|
2002-12-19 |
2007-08-27 |
Pfizer Prod Inc |
Pyrrolopyrimidine derivatives
|
UA80767C2
(en)
|
2002-12-20 |
2007-10-25 |
Pfizer Prod Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
US7098332B2
(en)
|
2002-12-20 |
2006-08-29 |
Hoffmann-La Roche Inc. |
5,8-Dihydro-6H-pyrido[2,3-d]pyrimidin-7-ones
|
US7488802B2
(en)
|
2002-12-23 |
2009-02-10 |
Wyeth |
Antibodies against PD-1
|
JP2004203749A
(ja)
|
2002-12-24 |
2004-07-22 |
Kanegafuchi Chem Ind Co Ltd |
SiH基を含有する含窒素有機系化合物の製造方法
|
DE602004021558D1
(de)
|
2003-01-17 |
2009-07-30 |
Warner Lambert Co |
2-aminopyridin-substituierteheterocyclen als inhibitoren der zellulären proliferation
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
US7135469B2
(en)
|
2003-03-18 |
2006-11-14 |
Bristol Myers Squibb, Co. |
Linear chain substituted monocyclic and bicyclic derivatives as factor Xa inhibitors
|
EP1608317B1
(en)
|
2003-03-25 |
2012-09-26 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
GB0308208D0
(en)
|
2003-04-09 |
2003-05-14 |
Glaxo Group Ltd |
Chemical compounds
|
BRPI0409366A
(pt)
|
2003-04-10 |
2006-04-25 |
Hoffmann La Roche |
compostos de pirimido
|
BRPI0409986A
(pt)
|
2003-05-05 |
2006-05-09 |
Hoffmann La Roche |
derivados de pirimidina fundida com atividade de crf
|
JP2004346145A
(ja)
|
2003-05-21 |
2004-12-09 |
Teijin Ltd |
イミド組成物およびそれからなる樹脂組成物、及びその製造方法
|
EP1651229A1
(en)
|
2003-05-23 |
2006-05-03 |
Chiron Corporation |
Guanidino-substituted quinazolinone compounds as mc4-r agonists
|
ES2341545T3
(es)
|
2003-06-06 |
2010-06-22 |
Arexis Ab |
Uso de compuestos heterociclicos condensados como inhibidores de scce para el tratamiento de enfermedades de la piel.
|
IL156495A0
(en)
|
2003-06-17 |
2004-01-04 |
Prochon Biotech Ltd |
Use of fgfr3 antagonists for treating t cell mediated diseases
|
JP4631703B2
(ja)
|
2003-06-18 |
2011-02-16 |
宇部興産株式会社 |
ピリミジン−4−オン化合物の製造方法
|
JP2005015395A
(ja)
|
2003-06-26 |
2005-01-20 |
Japan Science & Technology Agency |
新規ピリミドピリミジンヌクレオシドとその構造類縁体
|
AU2004253967B2
(en)
|
2003-07-03 |
2010-02-18 |
Cytovia, Inc. |
4-arylamino-quinazolines as activators of caspases and inducers of apoptosis
|
AR045037A1
(es)
|
2003-07-10 |
2005-10-12 |
Aventis Pharma Sa |
Tetrahidro-1h-pirazolo [3,4-c] piridinas sustituidas, composiciones que las contienen y su utilizacion.
|
BRPI0413005A
(pt)
|
2003-07-29 |
2006-09-26 |
Irm Llc |
compostos e composições como inibidores da proteìna cinase
|
US7390820B2
(en)
|
2003-08-25 |
2008-06-24 |
Amgen Inc. |
Substituted quinolinone derivatives and methods of use
|
CA2537916A1
(en)
|
2003-09-03 |
2005-03-31 |
Neurogen Corporation |
5-aryl-pyrazolo[4,3-d]pyrimidines, pyridines, and pyrazines and related compounds
|
JP2007505933A
(ja)
|
2003-09-18 |
2007-03-15 |
コンフォーマ・セラピューティクス・コーポレイション |
Hsp90インヒビターとしての新規なヘテロ環化合物
|
DE602004021611D1
(de)
|
2003-09-19 |
2009-07-30 |
Gilead Sciences Inc |
Azachinolinolphosphonatverbindungen als integraseinhibitoren
|
PE20050952A1
(es)
|
2003-09-24 |
2005-12-19 |
Novartis Ag |
Derivados de isoquinolina como inhibidores de b-raf
|
US7615557B2
(en)
|
2003-10-01 |
2009-11-10 |
Xention Limited |
Tetrahydro-naphthalene and urea derivatives
|
EP1673343A4
(en)
|
2003-10-08 |
2008-09-10 |
Irm Llc |
COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
|
US20090099165A1
(en)
|
2003-10-14 |
2009-04-16 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Protein Kinase Inhibitors
|
CN1897950A
(zh)
|
2003-10-14 |
2007-01-17 |
惠氏公司 |
稠合芳基和杂芳基衍生物及其使用方法
|
EP1687309A1
(en)
|
2003-11-17 |
2006-08-09 |
Pfizer Products Inc. |
Pyrrolopyrimidine compounds useful in treatment of cancer
|
WO2005056524A2
(en)
|
2003-12-09 |
2005-06-23 |
Euro-Celtique S.A. |
Therapeutic agents useful for treating pain
|
US20080188527A1
(en)
|
2003-12-23 |
2008-08-07 |
Cashman John R |
Synthetic Compounds and Derivatives as Modulators of Smoking or Nicotine Ingestion and Lung Cancer
|
KR100703068B1
(ko)
|
2003-12-30 |
2007-04-05 |
에스케이케미칼주식회사 |
피리딘 유도체와 이의 제조방법, 및 이를 포함하는약제조성물
|
US20050165032A1
(en)
|
2004-01-23 |
2005-07-28 |
Norman Mark H. |
Vanilloid receptor ligands and their use in treatments
|
AP2507A
(en)
|
2004-01-23 |
2012-11-16 |
Janssen Pharmaceutica Nv |
Quinoline derivatives and use thereof as mycobacterial inhibitors.
|
EP1715855A4
(en)
|
2004-01-29 |
2010-06-16 |
Elixir Pharmaceuticals Inc |
ANTIVIRAL DRUGS
|
GB0402137D0
(en)
|
2004-01-30 |
2004-03-03 |
Smithkline Beecham Corp |
Novel compounds
|
CN1918158B
(zh)
|
2004-02-14 |
2011-03-02 |
Irm责任有限公司 |
作为蛋白激酶抑制剂的化合物和组合物
|
EP1718645A1
(en)
|
2004-02-18 |
2006-11-08 |
Warner-Lambert Company LLC |
2-(pyridin-3-ylamino)-pyrido 2,3-d pyrimidin-7-ones
|
EP1720878A1
(en)
|
2004-02-27 |
2006-11-15 |
F.Hoffmann-La Roche Ag |
Heteroaryl-fused pyrazolo derivatives
|
CA2557575A1
(en)
|
2004-02-27 |
2005-09-15 |
F. Hoffmann-La Roche Ag |
Fused derivatives of pyrazole
|
US20080004263A1
(en)
|
2004-03-04 |
2008-01-03 |
Santora Vincent J |
Ligands of Follicle Stimulating Hormone Receptor and Methods of Use Thereof
|
JPWO2005085210A1
(ja)
|
2004-03-10 |
2008-01-17 |
小野薬品工業株式会社 |
ニトリル化合物およびその化合物を有効成分として含有する医薬組成物
|
KR100861434B1
(ko)
|
2004-03-29 |
2008-10-02 |
미쓰이 가가쿠 가부시키가이샤 |
신규 화합물 및 그 화합물을 사용한 유기 엘렉트로닉스소자
|
WO2005105097A2
(en)
|
2004-04-28 |
2005-11-10 |
Gpc Biotech Ag |
Pyridopyrimidines for treating inflammatory and other diseases
|
JP2005320288A
(ja)
|
2004-05-10 |
2005-11-17 |
Mitsui Chemicals Inc |
テトラカルボン酸誘導体、および該化合物を用いた電子写真感光体、電子写真装置
|
US20050256309A1
(en)
|
2004-05-12 |
2005-11-17 |
Altenbach Robert J |
Tri-and bi-cyclic heteroaryl histamine-3 receptor ligands
|
WO2005116035A1
(en)
|
2004-05-27 |
2005-12-08 |
Pfizer Products Inc. |
Pyrrolopyrimidine derivatives useful in cancer treatment
|
PE20060426A1
(es)
|
2004-06-02 |
2006-06-28 |
Schering Corp |
DERIVADOS DE ACIDO TARTARICO COMO INHIBIDORES DE MMPs, ADAMs, TACE Y TNF-alfa
|
MY144044A
(en)
|
2004-06-10 |
2011-07-29 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
PL1761528T3
(pl)
|
2004-06-11 |
2008-05-30 |
Japan Tobacco Inc |
Pochodne 5-amino-2,4,7-triokso-3,4,7,8-tetrahydro-2H-pirydo[2,3-D]pirymidyny i związki pokrewne do leczenia raka
|
GB0512324D0
(en)
|
2005-06-16 |
2005-07-27 |
Novartis Ag |
Organic compounds
|
JP2006028027A
(ja)
|
2004-07-12 |
2006-02-02 |
Mitsui Chemicals Inc |
テトラカルボン酸誘導体、および該化合物を用いた電子写真感光体、電子写真装置
|
DE602005013248D1
(de)
|
2004-08-31 |
2009-04-23 |
Hoffmann La Roche |
Amidderivate von 3-phenyldihydropyrimidoä4,5-düpyrimidinonen, deren herstellung und verwendung als pharmazeutische mittel
|
CA2576924A1
(en)
|
2004-08-31 |
2006-03-09 |
F. Hoffmann-La Roche Ag |
Amide derivatives of 7-amino-3-phenyl-dihydropyrimido [4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents
|
CN101048388A
(zh)
|
2004-08-31 |
2007-10-03 |
阿斯利康(瑞典)有限公司 |
喹唑啉酮衍生物及其作为B-Raf抑制剂的用途
|
DE102004042667A1
(de)
|
2004-09-01 |
2006-03-30 |
Ewald Dörken Ag |
Mehrschichtige Gebäudewand
|
TWI370147B
(en)
|
2004-09-10 |
2012-08-11 |
Ube Industries |
Modified polyimide resin and curable resin composition
|
CA2584412C
(en)
|
2004-09-14 |
2017-05-09 |
Minerva Biotechnologies Corporation |
Methods for diagnosis and treatment of cancer
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
WO2006038112A1
(en)
|
2004-10-01 |
2006-04-13 |
Warner-Lambert Company Llc |
Use of kinase inhibitors to promote neochondrogenesis
|
FR2876582B1
(fr)
|
2004-10-15 |
2007-01-05 |
Centre Nat Rech Scient Cnrse |
Utilisation de derives de pyrrolo-pyrazines pour la fabrication de medicaments pour le traitement de la mucoviscidose et de maladies liees a un defaut d'adressage des proteines dans les cellules
|
WO2006050162A2
(en)
|
2004-10-28 |
2006-05-11 |
Phenomix Corporation |
Imidazole derivatives
|
US7855205B2
(en)
|
2004-10-29 |
2010-12-21 |
Janssen Pharmaceutica Nv |
Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
|
US20060110462A1
(en)
|
2004-11-08 |
2006-05-25 |
Pavlos Papadopoulos |
Nanoparticulate compositions of tubulin inhibitor compounds
|
EP1824842A4
(en)
|
2004-11-18 |
2009-08-26 |
Incyte Corp |
INHIBITORS OF 11-HYDROXYL STEROID DEHYDROGENASE TYPE 1 AND METHOD OF USE
|
MX2007006103A
(es)
|
2004-11-22 |
2007-07-20 |
Vertex Pharma |
Pirrolopirazinas y pirazolopirazinas de utilidad como inhibidores de proteinquinasas.
|
EP1885352A2
(en)
|
2004-11-24 |
2008-02-13 |
Novartis AG |
Combinations comprising jak inhibitors and at least one of bcr-abl, flt-3, fak or raf kinase inhibitors
|
MY140748A
(en)
|
2004-12-06 |
2010-01-15 |
Astrazeneca Ab |
Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy
|
JP5111113B2
(ja)
|
2004-12-13 |
2012-12-26 |
サネシス ファーマシューティカルズ, インコーポレイテッド |
Rafキナーゼ阻害剤として有用なピリドピリミジノン、ジヒドロピリミドピリミジノンおよびプテリジノン
|
WO2006074293A2
(en)
|
2005-01-07 |
2006-07-13 |
President And Fellows Of Harvard College |
Bicyclic dihydropyrimidines as eg5 inhibitors
|
DE102005008310A1
(de)
|
2005-02-17 |
2006-08-24 |
Schering Ag |
Verwendung von CDKII Inhibitoren zur Fertilitätskontrolle
|
RU2007132865A
(ru)
|
2005-03-01 |
2009-03-10 |
Пфайзер Лимитед (GB) |
Применение ингибиторов pde7 для лечения невропатической боли
|
US7297700B2
(en)
|
2005-03-24 |
2007-11-20 |
Renovis, Inc. |
Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
|
CA2610292C
(en)
|
2005-03-30 |
2015-06-02 |
Minerva Biotechnologies Corporation |
Proliferation of muc1 expressing cells
|
JP2006284843A
(ja)
|
2005-03-31 |
2006-10-19 |
Mitsui Chemicals Inc |
テトラカルボン酸誘導体を用いた電子写真感光体、電子写真装置
|
US20060223993A1
(en)
|
2005-04-01 |
2006-10-05 |
Connor Daniel M |
Colorant compounds, intermediates, and compositions
|
JP2006316054A
(ja)
|
2005-04-15 |
2006-11-24 |
Tanabe Seiyaku Co Ltd |
高コンダクタンス型カルシウム感受性kチャネル開口薬
|
KR100781704B1
(ko)
|
2005-04-20 |
2007-12-03 |
에스케이케미칼주식회사 |
피리딘 유도체와 이의 제조방법, 및 이를 포함하는약제조성물
|
US7745451B2
(en)
|
2005-05-04 |
2010-06-29 |
Renovis, Inc. |
Tetrahydronaphthyridine and tetrahydropyrido[4,3-d]pyrimidine compounds and compositions thereof useful in the treatment of conditions associated with neurological and inflammatory disorders and dysfunctions
|
DK2161336T4
(en)
|
2005-05-09 |
2017-04-24 |
Ono Pharmaceutical Co |
Human monoclonal antibodies for programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapies
|
WO2006124731A2
(en)
|
2005-05-12 |
2006-11-23 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
KR20080025039A
(ko)
|
2005-05-13 |
2008-03-19 |
아이알엠 엘엘씨 |
단백질 키나제 억제제로서의 화합물 및 조성물
|
US20060279115A1
(en)
|
2005-06-09 |
2006-12-14 |
Ash Tisdelle |
Vehicular head and neck safety system and method
|
GB0512844D0
(en)
|
2005-06-23 |
2005-08-03 |
Novartis Ag |
Organic compounds
|
EP1907424B1
(en)
|
2005-07-01 |
2015-07-29 |
E. R. Squibb & Sons, L.L.C. |
Human monoclonal antibodies to programmed death ligand 1 (pd-l1)
|
WO2007013964A1
(en)
|
2005-07-22 |
2007-02-01 |
Sunesis Pharmaceuticals, Inc. |
Pyrazolo pyrimidines useful as aurora kinase inhibitors
|
WO2007013673A1
(en)
|
2005-07-29 |
2007-02-01 |
Astellas Pharma Inc. |
Fused heterocycles as lck inhibitors
|
ES2270715B1
(es)
|
2005-07-29 |
2008-04-01 |
Laboratorios Almirall S.A. |
Nuevos derivados de pirazina.
|
PT2099797E
(pt)
|
2005-08-09 |
2011-01-04 |
Irm Llc |
Compostos e composições como inibidores de proteína-quinase
|
CN101291938A
(zh)
|
2005-08-16 |
2008-10-22 |
Irm责任有限公司 |
作为蛋白激酶抑制剂的化合物和组合物
|
EP1919470A1
(en)
|
2005-08-25 |
2008-05-14 |
F.Hoffmann-La Roche Ag |
FUSED PYRAZOLE AS p38 MAP KINASE INHIBITORS
|
US7678917B2
(en)
|
2005-09-01 |
2010-03-16 |
Hoffman-La Roche Inc. |
Factor Xa inhibitors
|
EA200800549A1
(ru)
|
2005-09-06 |
2008-08-29 |
Смитклайн Бичем Корпорейшн |
Региоселективный способ получения бензимидазолтиофенов
|
KR20080046728A
(ko)
|
2005-09-15 |
2008-05-27 |
아스카 세이야쿠 가부시키가이샤 |
복소환 화합물, 그의 제조 방법 및 용도
|
US20070116984A1
(en)
|
2005-09-21 |
2007-05-24 |
Doosan Corporation |
Spiro-compound for electroluminescent display device and electroluminescent display device comprising the same
|
MX2008004024A
(es)
|
2005-09-23 |
2009-02-27 |
Schering Corp |
Antagonistas de receptor de glutamato metabotropico-1 tetraciclicos fusionados como agentes terapeuticos.
|
DE102005048072A1
(de)
|
2005-09-24 |
2007-04-05 |
Bayer Cropscience Ag |
Thiazole als Fungizide
|
JP5480503B2
(ja)
|
2005-10-07 |
2014-04-23 |
エクセリクシス, インク. |
PI3Kαのピリドピリミジノン型阻害剤
|
JP5270353B2
(ja)
|
2005-10-07 |
2013-08-21 |
エクセリクシス, インク. |
ホスファチジルイノシトール3−キナーゼインヒビターとその使用方法
|
WO2007061554A2
(en)
|
2005-10-21 |
2007-05-31 |
Purdue Research Foundation |
Dosage of 4-aminopyridine derivatives for treatment of central nervous system injuries
|
TW200800220A
(en)
|
2005-10-26 |
2008-01-01 |
Boehringer Ingelheim Int |
New (hetero)aryl compounds with MCH antagonistic activity and medicaments comprising these compounds
|
AU2006309013B2
(en)
|
2005-11-01 |
2012-06-28 |
Impact Biomedicines, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
US8604042B2
(en)
|
2005-11-01 |
2013-12-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
US8067457B2
(en)
|
2005-11-01 |
2011-11-29 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as antagonists of CCR2
|
CA2627839C
(en)
|
2005-11-02 |
2014-08-19 |
Bayer Healthcare Ag |
Pyrrolo[2,1-f] [1,2,4] triazin-4-ylamines igf-1r kinase inhibitors for the treatment of cancer and other hyperproliferative diseases
|
US20070161645A1
(en)
|
2005-11-02 |
2007-07-12 |
Targegen, Inc. |
Thiazole inhibitors targeting resistant kinase mutations
|
DK1954274T3
(da)
|
2005-11-10 |
2011-01-31 |
Chemocentryx Inc |
Substituerede quinoloner og fremgangsmåder til anvendelse
|
MY146564A
(en)
|
2005-11-10 |
2012-08-30 |
Msd Kk |
Aza-substituted spiro derivatives
|
WO2007058626A1
(en)
|
2005-11-16 |
2007-05-24 |
S*Bio Pte Ltd |
Indazole compounds
|
WO2007058392A1
(ja)
|
2005-11-21 |
2007-05-24 |
Japan Tobacco Inc. |
ヘテロ環化合物およびその医薬用途
|
KR101461680B1
(ko)
|
2005-12-02 |
2014-11-19 |
바이엘 헬스케어 엘엘씨 |
과다-증식성 장애 및 맥관형성과 관련된 질환의 치료에유용한 치환된 4-아미노-피롤로트리아진 유도체
|
PE20070855A1
(es)
|
2005-12-02 |
2007-10-14 |
Bayer Pharmaceuticals Corp |
Derivados de 4-amino-pirrolotriazina sustituida como inhibidores de quinasas
|
US8110687B2
(en)
|
2005-12-08 |
2012-02-07 |
Millennium Pharmaceuticals, Inc. |
Bicyclic compounds with kinase inhibitory activity
|
WO2007066189A2
(en)
|
2005-12-09 |
2007-06-14 |
Pfizer Products Inc. |
Salts, prodrugs and formulations of 1-[5-(4-amino-7-isopropyl-7h-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2-methoxy-phenyl]-3-(2,4-dichloro-phenyl)-urea
|
US20080318989A1
(en)
|
2005-12-19 |
2008-12-25 |
Burdick Daniel J |
Pyrimidine Kinase Inhibitors
|
MEP3808A
(xx)
|
2005-12-21 |
2010-02-10 |
Novartis Ag |
Derivati pirimidinil aril uree kao fgf inhibitori
|
WO2007084314A2
(en)
|
2006-01-12 |
2007-07-26 |
Incyte Corporation |
MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
|
UY30118A1
(es)
|
2006-01-31 |
2007-06-29 |
Tanabe Seiyaku Co |
Compueto amina trisustituido
|
US7427625B2
(en)
|
2006-02-08 |
2008-09-23 |
Janssen Pharmaceutica, N.V. |
Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors
|
BRPI0707945A2
(pt)
|
2006-02-17 |
2011-05-17 |
Pfizer Ltd |
derivados de 3-deazapurina como modulares de tlr7
|
CA2680789C
(en)
|
2006-03-28 |
2016-02-16 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
WO2007112347A1
(en)
|
2006-03-28 |
2007-10-04 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
EA200870385A1
(ru)
|
2006-03-29 |
2009-04-28 |
Фолдркс Фармасьютикалз, Инк. |
Ингибирование токсичности альфа-синуклеина
|
US7648973B2
(en)
|
2006-04-06 |
2010-01-19 |
Wisconsin Alumni Research Foundation |
2-methylene-1α,25-dihydroxy-19,21-dinorvitamin D3 analogs and uses thereof
|
JP2009533426A
(ja)
|
2006-04-13 |
2009-09-17 |
アストラゼネカ・アクチエボラーグ |
チオキサンチン誘導体およびそれらのmpo阻害剤としての用途
|
GB0608386D0
(en)
|
2006-04-27 |
2006-06-07 |
Senexis Ltd |
Compounds
|
WO2007125405A2
(en)
|
2006-05-01 |
2007-11-08 |
Pfizer Products Inc. |
Substituted 2-amino-fused heterocyclic compounds
|
RU2008148607A
(ru)
|
2006-05-11 |
2010-06-20 |
Айрм Ллк (Bm) |
Соединения и композиции в качестве ингибиторов протеинкиназы
|
US20090312321A1
(en)
|
2006-05-15 |
2009-12-17 |
Irm Llc |
Compositions and methods for fgf receptor kinases inhibitors
|
US7910108B2
(en)
|
2006-06-05 |
2011-03-22 |
Incyte Corporation |
Sheddase inhibitors combined with CD30-binding immunotherapeutics for the treatment of CD30 positive diseases
|
DE102006027156A1
(de)
|
2006-06-08 |
2007-12-13 |
Bayer Schering Pharma Ag |
Sulfimide als Proteinkinaseinhibitoren
|
AU2007262670B2
(en)
|
2006-06-22 |
2012-12-20 |
Prana Biotechnology Limited |
Method of treatment of glioma brain tumour
|
UY30444A1
(es)
|
2006-06-30 |
2008-01-31 |
Astrazeneca Ab |
Derivados de pirimidina, procesos para su preparacinn, composiciones farmaccuticos y usos de los mismos.
|
US20090281115A1
(en)
|
2006-06-30 |
2009-11-12 |
Board of Regents, The University of Texas System, a Texas University |
Inhibitors of c-kit and uses thereof
|
US8258129B2
(en)
|
2006-07-06 |
2012-09-04 |
Boehringer Ingelheim International Gmbh |
4-heterocycloalkylpyri(mi)dines, process for the preparation thereof and their use as medicaments
|
WO2008008234A1
(en)
|
2006-07-07 |
2008-01-17 |
Targegen, Inc. |
2-amino-5-substituted pyrimidine inhibitors
|
TW200811134A
(en)
|
2006-07-12 |
2008-03-01 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
WO2008012635A2
(en)
|
2006-07-26 |
2008-01-31 |
Pfizer Products Inc. |
Amine derivatives useful as anticancer agents
|
US20100222345A1
(en)
|
2006-08-09 |
2010-09-02 |
Caroline Jean Diaz |
Novel compounds as antagonists or inverse agonists for opioid receptors
|
EP2056829B9
(en)
|
2006-08-16 |
2012-09-26 |
Exelixis, Inc. |
Using pi3k and mek modulators in treatments of cancer
|
DE102006041382A1
(de)
|
2006-08-29 |
2008-03-20 |
Bayer Schering Pharma Ag |
Carbamoyl-Sulfoximide als Proteinkinaseinhibitoren
|
KR20090050094A
(ko)
|
2006-09-01 |
2009-05-19 |
사일린 파마슈티칼스, 인크 |
세린-트레오닌 단백질 키나제 및 parp 조절제
|
EP2471529A3
(en)
|
2006-09-05 |
2012-10-10 |
Emory University |
Kinase Inhibitors for Preventing or Treating Pathogen Infection and Method of Use Thereof
|
WO2008033858A2
(en)
|
2006-09-11 |
2008-03-20 |
Cgi Pharmaceuticals, Inc. |
Kinase inhibitors, and methods of using and identifying kinase inhibitors
|
US7897762B2
(en)
|
2006-09-14 |
2011-03-01 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of proliferative diseases
|
US7858587B2
(en)
|
2006-09-21 |
2010-12-28 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted difluorobenzyl-benzene derivates, medicaments containing such compounds, their use and process for their manufacture
|
WO2008034860A1
(en)
|
2006-09-22 |
2008-03-27 |
Glaxo Group Limited |
Pyrrolo[2, 3-b]pyridin-4-yl-benzenesulfonamide compounds as ikk2 inhibitors
|
CA2663366C
(en)
|
2006-10-02 |
2012-02-07 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
EP2077841A1
(en)
|
2006-10-30 |
2009-07-15 |
Glaxo Group Limited |
Novel substituted pyrimidines as cysteine protease inhibitors
|
US7858645B2
(en)
|
2006-11-01 |
2010-12-28 |
Hoffmann-La Roche Inc. |
Indazole derivatives
|
EP2081928B1
(en)
|
2006-11-10 |
2014-02-26 |
Bristol-Myers Squibb Company |
Pyrrolo-pyridine kinase inhibitors
|
US7902363B2
(en)
|
2006-11-17 |
2011-03-08 |
Polyera Corporation |
Diimide-based semiconductor materials and methods of preparing and using the same
|
US7892454B2
(en)
|
2006-11-17 |
2011-02-22 |
Polyera Corporation |
Acene-based organic semiconductor materials and methods of preparing and using the same
|
KR20080045536A
(ko)
|
2006-11-20 |
2008-05-23 |
에스케이케미칼주식회사 |
피리딘 화합물을 포함하는 간염 치료 및 예방 또는 간 보호효능을 갖는 약제 조성물
|
EP2104501B1
(en)
|
2006-12-13 |
2014-03-12 |
Merck Sharp & Dohme Corp. |
Methods of cancer treatment with igf1r inhibitors
|
WO2008071455A1
(en)
|
2006-12-15 |
2008-06-19 |
Bayer Schering Pharma Aktiengesellschaft |
Bicyclic acyltryptophanols
|
WO2008074068A1
(en)
|
2006-12-20 |
2008-06-26 |
Prana Biotechnology Limited |
Substituted quinoline derivatives as antiamyloidogeneic agents
|
US7737149B2
(en)
|
2006-12-21 |
2010-06-15 |
Astrazeneca Ab |
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
|
CA2672518A1
(en)
|
2006-12-22 |
2008-07-03 |
Novartis Ag |
Organic compounds and their uses
|
WO2008078091A1
(en)
|
2006-12-22 |
2008-07-03 |
Astex Therapeutics Limited |
Bicyclic heterocyclic compounds as fgfr inhibitors
|
AU2007337895C1
(en)
|
2006-12-22 |
2014-07-31 |
Astex Therapeutics Limited |
Tricyclic amine derivatives as protein tyrosine kinase inhibitors
|
FR2911140B1
(fr)
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Nouveaux derives de 2-anilino 4-heteroaryle pyrimides, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
EP2104676A2
(en)
|
2007-01-08 |
2009-09-30 |
Polyera Corporation |
Methods for preparing arene-bis(dicarboximide)-based semiconducting materials and related intermediates for preparing same
|
CN101007778A
(zh)
|
2007-01-10 |
2007-08-01 |
复旦大学 |
一种链延长型芴基双马来酰亚胺及其制备方法
|
AR064879A1
(es)
|
2007-01-12 |
2009-04-29 |
Astellas Pharma Inc |
Compuesto de piridina condensado
|
JP2010515760A
(ja)
|
2007-01-12 |
2010-05-13 |
バイオクライスト ファーマシューティカルズ, インコーポレイテッド |
抗ウイルス性ヌクレオシド類似体
|
FR2911604B1
(fr)
|
2007-01-19 |
2009-04-17 |
Sanofi Aventis Sa |
Derives de n-(heteroaryl-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
|
JP5358962B2
(ja)
|
2007-02-06 |
2013-12-04 |
住友化学株式会社 |
組成物及び該組成物を用いてなる発光素子
|
JP2008198769A
(ja)
|
2007-02-13 |
2008-08-28 |
Nippon Steel Chem Co Ltd |
有機エレクトロルミネッセント素子
|
BRPI0808422A2
(pt)
|
2007-03-06 |
2015-06-23 |
Novartis Ag |
Compostos orgânicos bicíclicos adequados para o tratamento de condições inflamatórias ou alérgicas
|
WO2008109177A2
(en)
|
2007-03-07 |
2008-09-12 |
Alantos Pharmaceuticals Holding, Inc. |
Metalloprotease inhibitors containing a heterocyclic moiety
|
BRPI0808888B8
(pt)
|
2007-03-12 |
2021-05-25 |
Cytopia Res Pty Ltd |
composto de fenil amino pirimidina para uso no tratamento de uma doença associada à quinase, processo para a preparação do composto, composição farmacêutica, e, implante
|
US20080234262A1
(en)
|
2007-03-21 |
2008-09-25 |
Wyeth |
Pyrazolopyrimidine analogs and their use as mtor kinase and pi3 kinase inhibitors
|
EP2121648A2
(en)
|
2007-03-21 |
2009-11-25 |
EPIX Pharmaceuticals, Inc. |
S1p receptor modulating compounds and use thereof
|
JP2010522177A
(ja)
|
2007-03-23 |
2010-07-01 |
アムジエン・インコーポレーテツド |
複素環化合物およびその使用
|
EP2896624B1
(en)
|
2007-03-28 |
2016-07-13 |
Atir Holding S.A. |
Heterotricyclic compounds as serotonergic and/or dopaminergic agents and uses thereof
|
KR20080091948A
(ko)
|
2007-04-10 |
2008-10-15 |
에스케이케미칼주식회사 |
락탐형 피리딘 화합물을 포함하는 허혈성 질환의 예방 및치료용 약학조성물
|
US20100112211A1
(en)
|
2007-04-12 |
2010-05-06 |
Advanced Technology Materials, Inc. |
Zirconium, hafnium, titanium, and silicon precursors for ald/cvd
|
CN101754961A
(zh)
|
2007-04-20 |
2010-06-23 |
先灵公司 |
嘧啶酮衍生物及其使用方法
|
EP1985612A1
(en)
|
2007-04-26 |
2008-10-29 |
Bayer Schering Pharma Aktiengesellschaft |
Arymethylen substituted N-Acyl-gamma-aminoalcohols
|
PE20090288A1
(es)
|
2007-05-10 |
2009-04-03 |
Smithkline Beecham Corp |
Derivados de quinoxalina como inhibidores de la pi3 quinasa
|
EP1990342A1
(en)
|
2007-05-10 |
2008-11-12 |
AEterna Zentaris GmbH |
Pyridopyrazine Derivatives, Process of Manufacturing and Uses thereof
|
WO2008144253A1
(en)
|
2007-05-14 |
2008-11-27 |
Irm Llc |
Protein kinase inhibitors and methods for using thereof
|
GB2449293A
(en)
|
2007-05-17 |
2008-11-19 |
Evotec |
Compounds having Hsp90 inhibitory activity
|
AU2008259776A1
(en)
|
2007-06-03 |
2008-12-11 |
Vanderbilt University |
Benzamide mGluR5 positive allosteric modulators and methods of making and using same
|
EP2166842A4
(en)
|
2007-06-07 |
2012-01-25 |
Merck Sharp & Dohme |
TRICYCLIC ANILIDHETEROCYCLES AS CGRP RECEPTOR ANTAGONISTS
|
US7928111B2
(en)
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
US8633186B2
(en)
|
2007-06-08 |
2014-01-21 |
Senomyx Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
EP2168966B1
(en)
|
2007-06-15 |
2016-09-28 |
Msd K.K. |
Bicycloaniline derivative
|
PL2170959T3
(pl)
|
2007-06-18 |
2014-03-31 |
Merck Sharp & Dohme |
Przeciwciała przeciwko ludzkiemu receptorowi programowanej śmierci PD-1
|
EP2018859A1
(en)
|
2007-07-26 |
2009-01-28 |
Bayer Schering Pharma Aktiengesellschaft |
Arylmethylene substituted N-acyl-beta-amino alcohols
|
PE20090506A1
(es)
|
2007-07-26 |
2009-05-28 |
Novartis Ag |
DERIVADOS DE IMIDAZO-[1,2-b]-PIRIDAZIN COMO INHIBIDORES DE ALK5 Y/O ALK4
|
EP2020404A1
(en)
|
2007-08-01 |
2009-02-04 |
Bayer Schering Pharma Aktiengesellschaft |
Cyanomethyl substituted N-Acyl Tryptamines
|
WO2009019518A1
(en)
|
2007-08-09 |
2009-02-12 |
Astrazeneca Ab |
Pyrimidine compounds having a fgfr inhibitory effect
|
WO2009021083A1
(en)
|
2007-08-09 |
2009-02-12 |
Smithkline Beecham Corporation |
Quinoxaline derivatives as pi3 kinase inhibitors
|
WO2009029625A1
(en)
|
2007-08-27 |
2009-03-05 |
Kalypsys, Inc. |
4- [heterocyclyl-methyl] -8-fluoro-quinolin-2-ones useful as nitric oxide synthase inhibitors
|
US7960400B2
(en)
|
2007-08-27 |
2011-06-14 |
Duquesne University Of The Holy Ghost |
Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof
|
ES2535166T3
(es)
|
2007-09-04 |
2015-05-06 |
The Scripps Research Institute |
Pirimidinil-aminas sustituidas como inhibidores de proteína-quinasas
|
WO2009030871A1
(en)
|
2007-09-07 |
2009-03-12 |
Vernalis R & D Ltd |
Pyrrolopyrimidine derivatives having hsp90 inhibitory activity
|
TW200920357A
(en)
|
2007-09-10 |
2009-05-16 |
Curis Inc |
HSP90 inhibitors containing a zinc binding moiety
|
BRPI0817527A2
(pt)
|
2007-10-01 |
2017-05-02 |
Isis Pharmaceuticals Inc |
modulação antissenso da expressão do receptor de fator de crescimento de fibroblasto humano 4
|
AU2008308092B2
(en)
|
2007-10-05 |
2013-07-11 |
Msd K.K. |
Benzoxazinone derivative
|
EP2209775A1
(en)
|
2007-10-09 |
2010-07-28 |
UCB Pharma, S.A. |
Heterobicyclic compounds as histamine h4-receptor antagonists
|
WO2009049018A1
(en)
|
2007-10-10 |
2009-04-16 |
Syndax Pharmaceuticals, Inc. |
Novel compounds and methods of using them
|
CN101821243B
(zh)
|
2007-10-11 |
2013-05-08 |
中国科学院上海药物研究所 |
一类嘧啶取代苯丙酸衍生物及其作为ppar激动剂的用途
|
GB0720038D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New compounds
|
GB0720041D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New Compounds
|
JP5273052B2
(ja)
|
2007-10-13 |
2013-08-28 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、表示装置及び照明装置
|
CA2702838A1
(en)
|
2007-10-16 |
2009-04-23 |
Wyeth Llc |
Thienopyrimidine and pyrazolopyrimidine compounds and their use as mtor kinase and pi3 kinase inhibitors
|
JP2011500778A
(ja)
|
2007-10-25 |
2011-01-06 |
アストラゼネカ・アクチエボラーグ |
ピリジン及びピラジン誘導体−083
|
RU2007139634A
(ru)
|
2007-10-25 |
2009-04-27 |
Сергей Олегович Бачурин (RU) |
Новые тиазол-, триазол- или оксадиазол-содержащие тетрациклические соединения
|
WO2009056886A1
(en)
|
2007-11-01 |
2009-05-07 |
Astrazeneca Ab |
Pyrimidine derivatives and their use as modulators of fgfr activity
|
EP3536687B8
(en)
|
2007-11-28 |
2021-09-08 |
Dana-Farber Cancer Institute, Inc. |
Small molecule myristate inhibitors of bcr-abl and methods of use
|
EP2231620A1
(en)
|
2007-12-03 |
2010-09-29 |
Boehringer Ingelheim International GmbH |
Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation
|
WO2009085185A1
(en)
|
2007-12-19 |
2009-07-09 |
Amgen Inc. |
Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors
|
US20100331333A1
(en)
|
2007-12-21 |
2010-12-30 |
Wyeth Llc |
Imidazo [1,2-B] Pyridazine Compounds
|
EP2219646A4
(en)
|
2007-12-21 |
2010-12-22 |
Univ Rochester |
METHOD FOR MODIFYING THE LIFETIME OF EUKARYOTIC ORGANISMS
|
WO2009086509A2
(en)
|
2007-12-27 |
2009-07-09 |
Purdue Research Foundation |
Reagents for biomolecular labeling, detection and quantification employing raman spectroscopy
|
FR2926297B1
(fr)
|
2008-01-10 |
2013-03-08 |
Centre Nat Rech Scient |
Molecules chimiques inhibitrices du mecanisme d'epissage pour traiter des maladies resultant d'anomalies d'epissage.
|
US8471009B2
(en)
|
2008-01-24 |
2013-06-25 |
Andrey Alexandrovich Ivashchenko |
(EN) 2-alkylamino-3-arylsulfonyl-cycloalcano [e OR d] pyrazolo [1,5-A]pyrimidines / antagonists of serotonin 5-HT6 receptors, methods for the production and the use thereof
|
CN101925606A
(zh)
|
2008-01-24 |
2010-12-22 |
Ucb医药有限公司 |
包含环丁氧基的化合物
|
EP2248814A4
(en)
|
2008-01-24 |
2011-01-12 |
Alla Chem Llc |
SUBSTITUTED CYCLOALKAN [E AND D] PYRAZOLO [1,5-A] PYRIMIDINES / ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS AND PROCESS FOR THEIR PREPARATION AND THEIR USE
|
CN101925301B
(zh)
|
2008-01-25 |
2014-09-17 |
高点制药有限责任公司 |
作为TNF-α合成调节剂和作为PDE4抑制剂的三环化合物
|
ES2494365T3
(es)
|
2008-01-30 |
2014-09-15 |
Genentech, Inc. |
Compuestos de pirazolopirimidina que inhiben PI3K y métodos de uso
|
EP2265270A1
(en)
|
2008-02-04 |
2010-12-29 |
OSI Pharmaceuticals, Inc. |
2-aminopyridine kinase inhibitors
|
RU2010137300A
(ru)
|
2008-02-22 |
2012-03-27 |
Ф. Хоффманн-Ля Рош Аг (Ch) |
Модуляторы бета-амилоида
|
CA2716330A1
(en)
|
2008-02-22 |
2009-08-27 |
Irm Llc |
Compounds and compositions as modulators of gpr119 activity
|
EP2265588B1
(en)
|
2008-02-27 |
2013-06-26 |
Vitae Pharmaceuticals, Inc. |
INHIBITORS OF 11ß -HYDROXYSTEROID DEHYDROGENASE TYPE 1
|
WO2009108827A1
(en)
|
2008-02-29 |
2009-09-03 |
Wyeth |
Fused tricyclic pyrazolo[1, 5-a]pyrimidines, methods for preparation and uses thereof
|
US8168757B2
(en)
|
2008-03-12 |
2012-05-01 |
Merck Sharp & Dohme Corp. |
PD-1 binding proteins
|
GB0804701D0
(en)
|
2008-03-13 |
2008-04-16 |
Amura Therapeutics Ltd |
Compounds
|
US8993580B2
(en)
|
2008-03-14 |
2015-03-31 |
Intellikine Llc |
Benzothiazole kinase inhibitors and methods of use
|
EP2252293B1
(en)
|
2008-03-14 |
2018-06-27 |
Intellikine, LLC |
Kinase inhibitors and methods of use
|
US20090246198A1
(en)
|
2008-03-31 |
2009-10-01 |
Takeda Pharmaceutical Company Limited |
Mapk/erk kinase inhibitors and methods of use thereof
|
WO2009122180A1
(en)
|
2008-04-02 |
2009-10-08 |
Medical Research Council |
Pyrimidine derivatives capable of inhibiting one or more kinases
|
US8436005B2
(en)
|
2008-04-03 |
2013-05-07 |
Abbott Laboratories |
Macrocyclic pyrimidine derivatives
|
JP5530422B2
(ja)
|
2008-04-07 |
2014-06-25 |
アムジエン・インコーポレーテツド |
細胞周期阻害薬としてのgem−二置換およびスピロ環式アミノピリジン/ピリミジン
|
WO2009124755A1
(en)
|
2008-04-08 |
2009-10-15 |
European Molecular Biology Laboratory (Embl) |
Compounds with novel medical uses and method of identifying such compounds
|
WO2009125809A1
(ja)
|
2008-04-11 |
2009-10-15 |
第一三共株式会社 |
ピペリジン誘導体
|
WO2009125808A1
(ja)
|
2008-04-11 |
2009-10-15 |
第一三共株式会社 |
アミノシクロヘキシル誘導体
|
EP2277881A4
(en)
|
2008-04-18 |
2011-09-07 |
Shionogi & Co |
HETEROCYCLIC COMPOUND HAVING INHIBITORY ACTIVITY ON P13K
|
NZ588830A
(en)
|
2008-04-22 |
2012-11-30 |
Portola Pharm Inc |
Inhibitors of protein kinases
|
US8309577B2
(en)
|
2008-04-23 |
2012-11-13 |
Bristol-Myers Squibb Company |
Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligands
|
US7863291B2
(en)
|
2008-04-23 |
2011-01-04 |
Bristol-Myers Squibb Company |
Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
|
CA2719868A1
(en)
|
2008-04-29 |
2009-11-05 |
F. Hoffmann-La Roche Ag |
Pyrimidinyl pyridone inhibitors of jnk.
|
JP5539963B2
(ja)
|
2008-04-29 |
2014-07-02 |
ノバルティス アーゲー |
線維芽細胞増殖因子受容体のキナーゼ活性のモジュレーションをモニタリングする方法、および該方法の使用
|
WO2009133127A1
(en)
|
2008-04-30 |
2009-11-05 |
Merck Serono S.A. |
Fused bicyclic compounds and use thereof as pi3k inhibitors
|
US9315449B2
(en)
|
2008-05-15 |
2016-04-19 |
Duke University |
Substituted pyrazoles as heat shock transcription factor activators
|
UA103478C2
(ru)
|
2008-05-23 |
2013-10-25 |
Новартіс Аг |
Производные хинолинов и хиноксалинов как ингибиторы протеинтирозинкиназы
|
WO2009144205A1
(en)
|
2008-05-30 |
2009-12-03 |
Basf Se |
Rylene-based semiconductor materials and methods of preparation and use thereof
|
WO2009148916A1
(en)
|
2008-06-03 |
2009-12-10 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
JP2011524868A
(ja)
|
2008-06-10 |
2011-09-08 |
ビーエーエスエフ ソシエタス・ヨーロピア |
新規の遷移金属錯体及びそれを有機発光ダイオードにおいて用いる使用−iii
|
EP2303885B1
(en)
|
2008-06-12 |
2013-07-03 |
Merck Sharp & Dohme Corp. |
Process for producing bicycloaniline derivatives
|
GB0810902D0
(en)
|
2008-06-13 |
2008-07-23 |
Astex Therapeutics Ltd |
New compounds
|
CN102123989A
(zh)
|
2008-06-19 |
2011-07-13 |
阿斯利康(瑞典)有限公司 |
吡唑化合物436
|
TW201004958A
(en)
|
2008-06-24 |
2010-02-01 |
Res Found Itsuu Lab |
Oxazolidinone derivatives having a fused ring
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
EP2303881A2
(en)
|
2008-07-14 |
2011-04-06 |
Gilead Sciences, Inc. |
Fused heterocyclyc inhibitors of histone deacetylase and/or cyclin-dependent kinases
|
WO2010007099A1
(en)
|
2008-07-15 |
2010-01-21 |
Cellzome Limited |
2-aminoimidazo[1,2-b]pyridazine derivatives as pi3k inhibitors
|
ES2552681T3
(es)
|
2008-07-15 |
2015-12-01 |
F. Hoffmann-La Roche Ag |
Nuevas fenil-imidazopiridinas y piridazinas
|
US20110118286A1
(en)
|
2008-07-16 |
2011-05-19 |
Santhosh Francis Neelamkavil |
Bicyclic heterocycle derivatives and their use as gpcr modulators
|
UY31982A
(es)
|
2008-07-16 |
2010-02-26 |
Boehringer Ingelheim Int |
Derivados de 1,2-dihidropiridin-3-carboxamidas n-sustituidas
|
EP2318404B1
(en)
|
2008-07-16 |
2013-08-21 |
Merck Sharp & Dohme Corp. |
Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
|
WO2010009735A2
(en)
|
2008-07-23 |
2010-01-28 |
Dako Denmark A/S |
Combinatorial analysis and repair
|
US8455477B2
(en)
|
2008-08-05 |
2013-06-04 |
Merck Sharp & Dohme Corp. |
Therapeutic compounds
|
WO2010015643A1
(en)
|
2008-08-06 |
2010-02-11 |
Novartis Ag |
New antiviral modified nucleosides
|
CN102177152A
(zh)
|
2008-08-11 |
2011-09-07 |
哈佛大学校长及研究员协会 |
用于抑制tRNA合成酶的卤夫酮(halofuginone)类似物和其用途
|
UY32049A
(es)
|
2008-08-14 |
2010-03-26 |
Takeda Pharmaceutical |
Inhibidores de cmet
|
JP2012501962A
(ja)
|
2008-09-10 |
2012-01-26 |
田辺三菱製薬株式会社 |
芳香族含窒素六員環化合物及びその使用
|
KR101814408B1
(ko)
|
2008-09-26 |
2018-01-04 |
다나-파버 캔서 인스티튜트 인크. |
인간 항-pd-1, pd-l1, 및 pd-l2 항체 및 그의 용도
|
US20100137313A1
(en)
|
2008-10-03 |
2010-06-03 |
Astrazeneca Ab |
Heterocyclic derivatives and methods of use thereof
|
WO2010045371A1
(en)
|
2008-10-15 |
2010-04-22 |
Gilead Palo Alto, Inc. |
Pyrido- and pyrimido (1, 2-a) pyrimidine compounds useful as stearoyl coa desaturase inhibitors
|
US8110578B2
(en)
|
2008-10-27 |
2012-02-07 |
Signal Pharmaceuticals, Llc |
Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway
|
UY32203A
(es)
|
2008-10-29 |
2010-05-31 |
Astrazeneca Ab |
Amino pirimidinas y su uso en terapia
|
US8476431B2
(en)
|
2008-11-03 |
2013-07-02 |
Itellikine LLC |
Benzoxazole kinase inhibitors and methods of use
|
WO2010052448A2
(en)
|
2008-11-05 |
2010-05-14 |
Ucb Pharma S.A. |
Fused pyrazine derivatives as kinase inhibitors
|
WO2010059552A1
(en)
|
2008-11-18 |
2010-05-27 |
Glaxosmithkline Llc |
Prolyl hydroxylase inhibitors
|
UY32251A
(es)
|
2008-11-20 |
2010-05-31 |
Glaxosmithkline Llc |
Compuestos quimicos
|
WO2010064621A1
(ja)
|
2008-12-03 |
2010-06-10 |
コニカミノルタホールディングス株式会社 |
有機エレクトロルミネッセンス素子、有機エレクトロルミネッセンス素子材料、表示装置及び照明装置
|
KR101061599B1
(ko)
|
2008-12-05 |
2011-09-02 |
한국과학기술연구원 |
비정상 세포 성장 질환의 치료를 위한 단백질 키나아제 저해제인 신규 인다졸 유도체, 이의 약학적으로 허용가능한염 및 이를 유효성분으로 함유하는 약학적 조성물
|
NZ593937A
(en)
|
2008-12-08 |
2014-05-30 |
Vm Pharma Llc |
Compositions of protein receptor tyrosine kinase inhibitors
|
PL2376535T3
(pl)
|
2008-12-09 |
2017-09-29 |
F.Hoffmann-La Roche Ag |
Przeciwciała ANTY-PD-L1 i ich zastosowanie do nasilania działania limfocytów T
|
US8110265B2
(en)
|
2008-12-09 |
2012-02-07 |
The Coca-Cola Company |
Pet container and compositions having enhanced mechanical properties and gas barrier properties
|
AU2009325400A1
(en)
|
2008-12-12 |
2010-06-17 |
Msd K.K. |
Dihydropyrimidopyrimidine derivatives
|
EP2376493B1
(en)
|
2008-12-12 |
2016-10-05 |
Msd K.K. |
Dihydropyrimidopyrimidine derivative
|
US8232273B2
(en)
|
2008-12-19 |
2012-07-31 |
Genentech, Inc. |
Heterocyclic compounds and methods of use
|
PA8852901A1
(es)
|
2008-12-22 |
2010-07-27 |
Lilly Co Eli |
Inhibidores de proteina cinasa
|
WO2010078421A1
(en)
|
2008-12-30 |
2010-07-08 |
Arqule, Inc. |
Substituted 5,6-dihydro-6-phenylbenzo[f] isoquinolin-2-amine compounds
|
CA2748276A1
(en)
|
2008-12-30 |
2010-07-08 |
Arqule, Inc. |
Substituted pyrazolo [3, 4-b] pyridine compounds
|
US9266890B2
(en)
|
2009-01-06 |
2016-02-23 |
Dana-Farber Cancer Institute, Inc. |
Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
|
JOP20190230A1
(ar)
|
2009-01-15 |
2017-06-16 |
Incyte Corp |
طرق لاصلاح مثبطات انزيم jak و المركبات الوسيطة المتعلقة به
|
WO2010083145A1
(en)
|
2009-01-16 |
2010-07-22 |
Merck Sharp & Dohme Corp. |
IMIDAZO[1,2-a]PYRIDINES AND IMIDAZO[1,2-b]PYRIDAZINES AS MARK INHIBITORS
|
DE102009007038A1
(de)
|
2009-02-02 |
2010-08-05 |
Merck Patent Gmbh |
Metallkomplexe
|
JP2010180147A
(ja)
|
2009-02-04 |
2010-08-19 |
Mitsubishi Gas Chemical Co Inc |
シアン酸エステル化合物、およびその硬化物
|
ES2629337T3
(es)
|
2009-02-09 |
2017-08-08 |
Inserm - Institut National De La Santé Et De La Recherche Médicale |
Anticuerpos contra PD-1 y anticuerpos contra PD-L1 y usos de los mismos
|
TW201038569A
(en)
|
2009-02-16 |
2010-11-01 |
Abbott Gmbh & Co Kg |
Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
|
TW201035102A
(en)
|
2009-03-04 |
2010-10-01 |
Gruenethal Gmbh |
Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
|
WO2010103306A1
(en)
|
2009-03-10 |
2010-09-16 |
Astrazeneca Uk Limited |
Benzimidazole derivatives and their use as antivaral agents
|
JP5615261B2
(ja)
|
2009-03-11 |
2014-10-29 |
学校法人関西学院 |
多環芳香族化合物
|
AU2010226826A1
(en)
|
2009-03-18 |
2011-10-13 |
Merck Sharp & Dohme Corp. |
Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
|
KR101316982B1
(ko)
|
2009-03-23 |
2013-10-15 |
일라이 릴리 앤드 캄파니 |
신경계 장애를 검출하기 위한 조영제
|
EP2411370B1
(en)
|
2009-03-27 |
2015-04-22 |
AbbVie Inc. |
Compounds as cannabinoid receptor ligands
|
TW201102391A
(en)
|
2009-03-31 |
2011-01-16 |
Biogen Idec Inc |
Certain substituted pyrimidines, pharmaceutical compositions thereof, and methods for their use
|
US8481525B2
(en)
|
2009-04-06 |
2013-07-09 |
University Of Health Network |
Kinase inhibitors and method of treating cancer with same
|
WO2010117323A1
(en)
|
2009-04-07 |
2010-10-14 |
Astrazeneca Ab |
Method and apparatus for producing heat energy and carbon dioxide
|
GB0906470D0
(en)
|
2009-04-15 |
2009-05-20 |
Astex Therapeutics Ltd |
New compounds
|
GB0906472D0
(en)
|
2009-04-15 |
2009-05-20 |
Astex Therapeutics Ltd |
New compounds
|
JP5531446B2
(ja)
|
2009-04-20 |
2014-06-25 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、有機エレクトロルミネッセンス素子材料、表示装置および照明装置
|
ES2347630B1
(es)
|
2009-04-29 |
2011-09-08 |
Universitat Ramon Llull |
Sintesis y usos de 4-cianopentanoatos y 4-cianopentenoatos sustituidos.
|
EP2424368B1
(en)
|
2009-04-29 |
2014-12-31 |
Locus Pharmaceuticals, Inc. |
Pyrrolotriazine compounds
|
WO2010127212A1
(en)
|
2009-04-30 |
2010-11-04 |
Forest Laboratories Holdings Limited |
Inhibitors of acetyl-coa carboxylase
|
AR078411A1
(es)
|
2009-05-07 |
2011-11-09 |
Lilly Co Eli |
Compuesto de vinil imidazolilo y composicion farmaceutica que lo comprende
|
JP5600891B2
(ja)
|
2009-05-15 |
2014-10-08 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、表示装置および照明装置
|
JP5604808B2
(ja)
|
2009-05-20 |
2014-10-15 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、表示装置及び照明装置
|
JP5629980B2
(ja)
|
2009-05-22 |
2014-11-26 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、表示装置及び照明装置
|
JP5568889B2
(ja)
|
2009-05-22 |
2014-08-13 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、表示装置、照明装置及び有機エレクトロルミネッセンス素子材料
|
WO2010136031A1
(en)
|
2009-05-27 |
2010-12-02 |
Københavns Universitet |
Fibroblast growth factor receptor-derived peptides binding to ncam
|
JP5499519B2
(ja)
|
2009-05-27 |
2014-05-21 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、表示装置及び照明装置
|
GB0910003D0
(en)
|
2009-06-11 |
2009-07-22 |
Univ Leuven Kath |
Novel compounds for the treatment of neurodegenerative diseases
|
JP5600894B2
(ja)
|
2009-06-24 |
2014-10-08 |
コニカミノルタ株式会社 |
白色有機エレクトロルミネッセンス素子、表示装置及び照明装置
|
RS56352B2
(sr)
|
2009-06-25 |
2023-02-28 |
Alkermes Pharma Ireland Ltd |
Heterociklična jedinjenja za lečenje neuroloških i psiholoških poremećaja
|
CN102471261B
(zh)
|
2009-06-30 |
2014-10-29 |
日本瑞翁株式会社 |
二芳基胺化合物、以及抗老化剂、聚合物组合物、橡胶交联物及其成型品、以及二芳基胺化合物的制备方法
|
EP2455370A1
(en)
|
2009-07-17 |
2012-05-23 |
Shionogi&Co., Ltd. |
Pharmaceutical product containing lactam or benzene sulfonamide compound
|
WO2011011597A1
(en)
|
2009-07-24 |
2011-01-27 |
Duke University |
Prochelators useful for inhibiting metal-associated toxicity
|
FR2948568B1
(fr)
|
2009-07-30 |
2012-08-24 |
Sanofi Aventis |
Formulation pharmaceutique
|
TWI468402B
(zh)
|
2009-07-31 |
2015-01-11 |
必治妥美雅史谷比公司 |
降低β-類澱粉生成之化合物
|
SG178106A1
(en)
|
2009-08-05 |
2012-03-29 |
Versitech Ltd |
Antiviral compounds and methods of making and using thereof
|
JP2012197231A
(ja)
|
2009-08-06 |
2012-10-18 |
Oncotherapy Science Ltd |
Ttk阻害作用を有するピリジンおよびピリミジン誘導体
|
CN102574836B
(zh)
|
2009-08-07 |
2014-04-16 |
中外制药株式会社 |
氨基吡唑衍生物
|
WO2011018894A1
(en)
|
2009-08-10 |
2011-02-17 |
Raqualia Pharma Inc. |
Pyrrolopyrimidine derivatives as potassium channel modulators
|
SG10201404886PA
(en)
|
2009-08-17 |
2014-10-30 |
Intellikine Llc |
Heterocyclic compounds and uses thereof
|
JP5577650B2
(ja)
|
2009-08-24 |
2014-08-27 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、有機エレクトロルミネッセンス素子材料、表示装置及び照明装置
|
KR101184115B1
(ko)
|
2009-08-31 |
2012-09-18 |
일동제약주식회사 |
신규 펩티드 데포르밀라제 저해제 화합물 및 그 제조방법
|
MX2012002274A
(es)
|
2009-09-03 |
2012-09-07 |
Bioenergenix |
Compuestos heterociclicos para la inhibicion de pask.
|
CN102596932A
(zh)
|
2009-09-04 |
2012-07-18 |
拜耳医药股份有限公司 |
作为酪氨酸苏氨酸激酶抑制剂的取代氨基喹喔啉
|
WO2011031740A1
(en)
|
2009-09-09 |
2011-03-17 |
Achaogen, Inc. |
Antibacterial fluoroquinolone analogs
|
EP2475666A2
(en)
|
2009-09-11 |
2012-07-18 |
Trius Therapeutics, Inc. |
Gyrase inhibitors
|
WO2011041143A1
(en)
|
2009-10-01 |
2011-04-07 |
Merck Sharp & Dohme Corp. |
HETEROCYCLIC-FUSED PYRAZOLO[4,3-c]PYRIDIN-3-ONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS
|
US8466155B2
(en)
|
2009-10-02 |
2013-06-18 |
Boehringer Ingelheim International Gmbh |
Pyrimidines
|
GB0917571D0
(en)
|
2009-10-07 |
2009-11-25 |
Karobio Ab |
Novel estrogen receptor ligands
|
EP2308866A1
(de)
|
2009-10-09 |
2011-04-13 |
Bayer CropScience AG |
Phenylpyri(mi)dinylpyrazole und ihre Verwendung als Fungizide
|
FR2951172B1
(fr)
|
2009-10-13 |
2014-09-26 |
Pf Medicament |
Derives pyrazolopyridines en tant qu'agent anticancereux
|
CN102666537A
(zh)
|
2009-10-20 |
2012-09-12 |
艾格尔生物制药股份有限公司 |
治疗黄病毒科病毒感染的氮杂吲唑
|
KR20110043270A
(ko)
|
2009-10-21 |
2011-04-27 |
(주)씨에스엘쏠라 |
유기발광화합물 및 이를 구비한 유기발광소자
|
NZ598933A
(en)
|
2009-10-22 |
2013-04-26 |
Gilead Sciences Inc |
Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections
|
WO2011050245A1
(en)
|
2009-10-23 |
2011-04-28 |
Yangbo Feng |
Bicyclic heteroaryls as kinase inhibitors
|
EP3091021B1
(en)
|
2009-10-26 |
2019-08-28 |
Signal Pharmaceuticals, LLC |
Methods of synthesis and purification of heteroaryl compounds
|
WO2011051425A1
(en)
|
2009-10-30 |
2011-05-05 |
Novartis Ag |
N-oxide of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea
|
KR20110049217A
(ko)
|
2009-11-04 |
2011-05-12 |
다우어드밴스드디스플레이머티리얼 유한회사 |
신규한 유기 발광 화합물 및 이를 채용하고 있는 유기 전계 발광 소자
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
PE20121327A1
(es)
|
2009-11-06 |
2012-10-18 |
Plexxikon Inc |
Compuestos y metodos para la modulacion de cinasas, e indicaciones para ello
|
MX2012005332A
(es)
|
2009-11-13 |
2012-10-15 |
Oscotec Inc |
Inhibidores de cinasa.
|
RU2012125070A
(ru)
|
2009-11-18 |
2013-12-27 |
Плексксикон, Инк. |
Соединения и способы модулирования киназы и показания к их применению
|
JP2013032290A
(ja)
|
2009-11-20 |
2013-02-14 |
Dainippon Sumitomo Pharma Co Ltd |
新規縮合ピリミジン誘導体
|
WO2011062885A1
(en)
|
2009-11-23 |
2011-05-26 |
Schering Corporation |
Fused bicyclic pyrimidine derivatives and methods of use thereof
|
JP2013512251A
(ja)
|
2009-11-24 |
2013-04-11 |
アンプリミューン、インコーポレーテッド |
Pd−l1/pd−l2の同時阻害
|
EP2332939A1
(en)
|
2009-11-26 |
2011-06-15 |
Æterna Zentaris GmbH |
Novel Naphthyridine derivatives and the use thereof as kinase inhibitors
|
AU2010326030A1
(en)
|
2009-12-01 |
2012-06-07 |
Abbvie Inc. |
Novel tricyclic compounds
|
JP2011116840A
(ja)
|
2009-12-02 |
2011-06-16 |
Fujifilm Corp |
顔料微粒子分散体、これを用いた光硬化性組成物及びカラーフィルタ
|
AR079257A1
(es)
|
2009-12-07 |
2012-01-04 |
Novartis Ag |
Formas cristalinas de 3-(2,6-dicloro-3-5-dimetoxi-fenil)-1-{6-[4-(4-etil-piperazin-1-il)-fenil-amino]-pirimidin-4-il}-1-metil-urea y sales de las mismas
|
GEP20146125B
(en)
|
2009-12-17 |
2014-07-25 |
Merck Canada |
Aminopyrimidines as syk inhibitors
|
JP2013514986A
(ja)
|
2009-12-18 |
2013-05-02 |
ノバルティス アーゲー |
血液癌の処置方法
|
SG181917A1
(en)
|
2009-12-22 |
2012-08-30 |
Vertex Pharma |
Isoindolinone inhibitors of phosphatidylinositol 3-kinase
|
FR2954315B1
(fr)
|
2009-12-23 |
2012-02-24 |
Galderma Res & Dev |
Nouveaux derives phenoliques, et leur utilisation pharmaceutique ou cosmetique
|
FR2954317B1
(fr)
|
2009-12-23 |
2012-01-27 |
Galderma Res & Dev |
Nouveaux derives phenoliques, et leur utilisation pharmaceutique ou cosmetique
|
US20110207736A1
(en)
|
2009-12-23 |
2011-08-25 |
Gatekeeper Pharmaceuticals, Inc. |
Compounds that modulate egfr activity and methods for treating or preventing conditions therewith
|
US20130096115A1
(en)
|
2009-12-28 |
2013-04-18 |
Afraxis, Inc. |
Methods for treating autism
|
US8440828B2
(en)
|
2009-12-29 |
2013-05-14 |
Polyera Corporation |
Organic semiconductors and devices incorporating same
|
CA2784807C
(en)
|
2009-12-29 |
2021-12-14 |
Dana-Farber Cancer Institute, Inc. |
Type ii raf kinase inhibitors
|
WO2011080755A1
(en)
|
2009-12-29 |
2011-07-07 |
Advinus Therapeutics Private Limited |
Fused nitrogen heterocyclic compounds, process of preparation and uses thereof
|
EP2519525A4
(en)
|
2009-12-30 |
2013-06-12 |
Arqule Inc |
SUBSTITUTED PYRROLO-AMINOPYRIMIDINE COMPOUNDS
|
WO2011082267A2
(en)
|
2009-12-30 |
2011-07-07 |
Arqule, Inc. |
Substituted triazolo-pyrazine compounds
|
US8563567B2
(en)
|
2009-12-30 |
2013-10-22 |
Arqule, Inc. |
Substituted heterocyclic compounds
|
CN102115026A
(zh)
|
2009-12-31 |
2011-07-06 |
清华大学 |
一维纳米结构、其制备方法及一维纳米结构作标记的方法
|
WO2011082400A2
(en)
|
2010-01-04 |
2011-07-07 |
President And Fellows Of Harvard College |
Modulators of immunoinhibitory receptor pd-1, and methods of use thereof
|
AR079975A1
(es)
|
2010-01-06 |
2012-03-07 |
British Columbia Cancer Agency |
Agentes terapeuticos derivados de bisfenol u metodos para su uso, composiciones farmaceuticas y uso de los mismos
|
KR101483215B1
(ko)
|
2010-01-29 |
2015-01-16 |
한미약품 주식회사 |
단백질 키나아제 저해활성을 갖는 비시클릭 헤테로아릴 유도체
|
WO2011094890A1
(en)
|
2010-02-02 |
2011-08-11 |
Argusina Inc. |
Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
|
WO2011097717A1
(en)
|
2010-02-15 |
2011-08-18 |
University Of Victoria Innovation And Development Corporation |
Synthesis of bicyclic compounds and method for their use as therapeutic agents
|
MX2012009561A
(es)
|
2010-02-17 |
2012-11-23 |
Amgen Inc |
Carboxamidas como inhibidores de canales de sodio dependientes del voltaje.
|
SA111320200B1
(ar)
|
2010-02-17 |
2014-02-16 |
ديبيوفارم اس ايه |
مركبات ثنائية الحلقة واستخداماتها كمثبطات c-src/jak مزدوجة
|
EP2536410B1
(en)
|
2010-02-18 |
2015-09-23 |
Merck Sharp & Dohme Corp. |
Substituted pyrimidine derivatives and their use in treating viral infections
|
US9150809B2
(en)
|
2010-02-18 |
2015-10-06 |
Ntn Corporation |
Thickener, grease, method for producing the same, and grease-packed bearing
|
WO2011103460A1
(en)
|
2010-02-18 |
2011-08-25 |
Medivation Technologies, Inc. |
Fused tetracyclic pyrido[4,3-b]indole and pyrido[3,4-b]ondole derivatives and methods of use
|
UY33227A
(es)
|
2010-02-19 |
2011-09-30 |
Novartis Ag |
Compuestos de pirrolopirimidina como inhibidores de la cdk4/6
|
WO2011103557A1
(en)
|
2010-02-22 |
2011-08-25 |
Advanced Cancer Therapeutics, Llc |
Small molecule inhibitors of pfkfb3 and glycolytic flux and their methods of use as anti-cancer therapeutics
|
KR101719173B1
(ko)
|
2010-02-26 |
2017-03-23 |
신닛테츠 수미킨 가가쿠 가부시키가이샤 |
유기 전계 발광 소자
|
US20130045203A1
(en)
|
2010-03-02 |
2013-02-21 |
Emory University |
Uses of Noscapine and Derivatives in Subjects Diagnosed with FAP
|
WO2011111880A1
(ko)
|
2010-03-08 |
2011-09-15 |
주식회사 메디젠텍 |
세포핵에서 세포질로의 gsk3의 이동을 억제하는 화합물을 함유하는 세포핵에서 세포질로의 gsk3 이동에 의해 발생되는 질환의 치료 또는 예방용 약학적 조성물
|
US20110237599A1
(en)
|
2010-03-10 |
2011-09-29 |
Kalypsys, Inc. |
Heterocyclic inhibitors of histamine receptors for the treatment of disease
|
BR112012022943A2
(pt)
|
2010-03-11 |
2018-06-05 |
Gilead Connecticut Inc |
inibidores de syk de imidazopiridnas
|
CN103080093A
(zh)
|
2010-03-16 |
2013-05-01 |
达纳-法伯癌症研究所公司 |
吲唑化合物及其应用
|
RU2640862C2
(ru)
|
2010-03-24 |
2018-01-18 |
Амитек Терапетикс Солюшинс, Инк. |
Гетероциклические соединения, эффективные для ингибирования киназы
|
JP5752232B2
(ja)
|
2010-03-31 |
2015-07-22 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
プロテインキナーゼ阻害剤としての置換ピロロトリアジン化合物
|
CN102153551B
(zh)
|
2010-04-02 |
2012-04-25 |
济南海乐医药技术开发有限公司 |
基于吲唑或氮杂吲唑的双芳基脲或硫脲类结构抗肿瘤药物
|
JP5724204B2
(ja)
|
2010-04-07 |
2015-05-27 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、表示装置、及び照明装置
|
JP6067550B2
(ja)
|
2010-04-13 |
2017-01-25 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
2,4−ピリミジンジアミン化合物およびそのプロドラッグならびにそれらの使用
|
AU2011239999B2
(en)
|
2010-04-16 |
2014-04-03 |
Novartis Ag |
Organic compound for use in the treatment of liver cancer
|
CN102939283B
(zh)
|
2010-04-22 |
2015-06-03 |
詹森药业有限公司 |
可用作己酮糖激酶抑制剂的吲唑化合物
|
JP2013525366A
(ja)
|
2010-04-23 |
2013-06-20 |
キネタ・インコーポレイテツド |
抗ウイルス性化合物
|
AR081331A1
(es)
|
2010-04-23 |
2012-08-08 |
Cytokinetics Inc |
Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
|
GB201007286D0
(en)
|
2010-04-30 |
2010-06-16 |
Astex Therapeutics Ltd |
New compounds
|
US8481555B2
(en)
|
2010-04-30 |
2013-07-09 |
Bristol-Myers Squibb Company |
Aza-bicyclic amine N-oxide compounds as alpha-7 nicotinic acetylcholine receptor ligand pro-drugs
|
US8759398B2
(en)
|
2010-05-03 |
2014-06-24 |
Biolink Life Sciences, Inc. |
Phosphorus binder composition for treatment of hyperphosphatemia
|
US20130137709A1
(en)
|
2010-05-05 |
2013-05-30 |
Nathanael S. Gray |
Compounds that modulate EGFR activity and methods for treating or preventing conditions therewith
|
TWI513694B
(zh)
|
2010-05-11 |
2015-12-21 |
Amgen Inc |
抑制間變性淋巴瘤激酶的嘧啶化合物
|
CN102905723A
(zh)
|
2010-05-11 |
2013-01-30 |
Aveo制药公司 |
抗fgfr2抗体
|
CA2798831A1
(en)
|
2010-05-11 |
2011-11-17 |
Pfizer Inc. |
Morpholine compounds as mineralocorticoid receptor antagonists
|
JP2013526542A
(ja)
|
2010-05-12 |
2013-06-24 |
アッヴィ・インコーポレイテッド |
キナーゼのインダゾール阻害薬
|
WO2011143475A1
(en)
|
2010-05-12 |
2011-11-17 |
Spectrum Pharmaceuticals, Inc. |
Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use
|
GB201008134D0
(en)
|
2010-05-14 |
2010-06-30 |
Medical Res Council Technology |
Compounds
|
WO2011147198A1
(en)
|
2010-05-28 |
2011-12-01 |
Versitech Limited |
Compounds and methods for treatment of proliferative diseases
|
WO2011147199A1
(en)
|
2010-05-28 |
2011-12-01 |
Versitech Limited |
Compounds and methods for treating viral infections
|
JP5713367B2
(ja)
|
2010-06-04 |
2015-05-07 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
Lrrk2モジュレーターとしてのアミノピリミジン誘導体
|
WO2011153553A2
(en)
|
2010-06-04 |
2011-12-08 |
The Regents Of The University Of California |
Methods and compositions for kinase inhibition
|
WO2011155983A1
(en)
|
2010-06-07 |
2011-12-15 |
Bikam Pharmaceuticals Inc. |
Opsin-binding ligands, compositions and methods of use
|
TW201210597A
(en)
|
2010-06-09 |
2012-03-16 |
Gilead Sciences Inc |
Inhibitors of hepatitis C virus
|
US8299117B2
(en)
|
2010-06-16 |
2012-10-30 |
Metabolex Inc. |
GPR120 receptor agonists and uses thereof
|
JP2013532153A
(ja)
|
2010-06-18 |
2013-08-15 |
ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド |
慢性免疫病に対する免疫治療のためのtim−3およびpd−1に対する二重特異性抗体
|
WO2011163330A1
(en)
|
2010-06-24 |
2011-12-29 |
Merck Sharp & Dohme Corp. |
Novel heterocyclic compounds as erk inhibitors
|
US8907053B2
(en)
|
2010-06-25 |
2014-12-09 |
Aurigene Discovery Technologies Limited |
Immunosuppression modulating compounds
|
US8933070B2
(en)
|
2010-07-02 |
2015-01-13 |
University Health Network |
Methods of targeting PTEN mutant diseases and compositions therefor
|
FR2962437B1
(fr)
|
2010-07-06 |
2012-08-17 |
Sanofi Aventis |
Derives d'imidazopyridine, leur procede de preparation et leur application en therapeutique
|
CN103080106A
(zh)
|
2010-07-06 |
2013-05-01 |
诺瓦提斯公司 |
用作激酶抑制剂的环醚化合物
|
FR2962438B1
(fr)
|
2010-07-06 |
2012-08-17 |
Sanofi Aventis |
Derives d'indolizines, procedes de preparation et application en therapeutique
|
CA2804648C
(en)
|
2010-07-09 |
2019-01-22 |
The Walter And Eliza Hall Institute Of Medical Research |
Protein kinase inhibitors and methods of treatment
|
WO2012009258A2
(en)
|
2010-07-13 |
2012-01-19 |
Edward Roberts |
Peptidomimetic galanin receptor modulators
|
EP2595996A2
(en)
|
2010-07-14 |
2013-05-29 |
Merck Sharp & Dohme Corp. |
Tricyclic compounds as allosteric modulators of metabotropic glutamate receptors
|
TW201206946A
(en)
|
2010-07-15 |
2012-02-16 |
Bristol Myers Squibb Co |
Compounds for the reduction of beta-amyloid production
|
WO2012008564A1
(ja)
|
2010-07-16 |
2012-01-19 |
協和発酵キリン株式会社 |
含窒素芳香族複素環誘導体
|
JP5789259B2
(ja)
|
2010-07-16 |
2015-10-07 |
協和発酵キリン株式会社 |
含窒素芳香族複素環誘導体
|
US8987273B2
(en)
|
2010-07-28 |
2015-03-24 |
Bayer Intellectual Property Gmbh |
Substituted imidazo[1,2-B]pyridazines
|
EP2413140A1
(en)
|
2010-07-29 |
2012-02-01 |
Sanofi |
Method for identifying a compound having an antiarrhythmic effect as well as uses relating thereto
|
EP2905281A1
(en)
|
2010-07-30 |
2015-08-12 |
Rohm And Haas Electronic Materials Korea Ltd. |
Organic electroluminescent device employing organic light emitting compound as light emitting material
|
WO2012019093A1
(en)
|
2010-08-05 |
2012-02-09 |
Human Biomolecular Research Institute |
Synthetic compounds and methods to decrease nicotine self-administration
|
US9051280B2
(en)
|
2010-08-13 |
2015-06-09 |
AbbVie Deutschland GmbH & Co. KG |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US8883839B2
(en)
|
2010-08-13 |
2014-11-11 |
Abbott Laboratories |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
WO2012027239A1
(en)
|
2010-08-23 |
2012-03-01 |
Schering Corporation |
NOVEL PYRAZOLO[1,5-a]PYRROLO[3,2-e]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
|
US8883801B2
(en)
|
2010-08-23 |
2014-11-11 |
Merck Sharp & Dohme Corp. |
Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors
|
ES2537190T3
(es)
|
2010-09-01 |
2015-06-03 |
Gilead Connecticut, Inc. |
Piridazinonas, procedimiento de preparación y procedimientos de utilización de las mismas
|
KR101837223B1
(ko)
|
2010-09-01 |
2018-03-09 |
질레드 코네티컷 인코포레이티드 |
피리디논/피라지논, 그의 제조 방법 및 사용 방법
|
AR082799A1
(es)
|
2010-09-08 |
2013-01-09 |
Ucb Pharma Sa |
Derivados de quinolina y quinoxalina como inhibidores de quinasa
|
WO2012032065A1
(en)
|
2010-09-08 |
2012-03-15 |
Glaxo Group Limited |
Indazole derivatives for use in the treatment of influenza virus infection
|
HUE026059T2
(en)
|
2010-09-08 |
2016-05-30 |
Glaxosmithkline Ip Dev Ltd |
N- [5- [4- (5 - {[(2R, 6S) -2,6-dimethyl-4-morpholinyl] methyl} -1,3-oxazol-2-yl) -1H-indazol-6-yl ] Polymorphs and salts of 2 - (methyloxy) -3-pyridinyl] methanesulfonamide
|
TWI541243B
(zh)
|
2010-09-10 |
2016-07-11 |
拜耳知識產權公司 |
經取代咪唑并嗒
|
EP2618219A4
(en)
|
2010-09-14 |
2015-03-18 |
Hodogaya Chemical Co Ltd |
CHARGE CONTROL AGENT AND TONER USING THE SAME
|
CN102399220A
(zh)
|
2010-09-15 |
2012-04-04 |
黄振华 |
三并环类PI3K和mTOR双重抑制剂
|
CN102399233B
(zh)
|
2010-09-15 |
2014-08-13 |
山东轩竹医药科技有限公司 |
PI3K和mTOR双重抑制剂类化合物
|
WO2012036233A1
(ja)
|
2010-09-17 |
2012-03-22 |
塩野義製薬株式会社 |
メラニン凝集ホルモン受容体アンタゴニスト活性を有する縮合へテロ環誘導体
|
GB201015949D0
(en)
|
2010-09-22 |
2010-11-03 |
Medical Res Council Technology |
Compounds
|
JO3062B1
(ar)
|
2010-10-05 |
2017-03-15 |
Lilly Co Eli |
R)-(e)-2-(4-(2-(5-(1-(3، 5-داي كلورو بيريدين-4-يل)إيثوكسي)-1h-إندازول-3-يل)?ينيل)-1h-بيرازول-1-يل)إيثانول بلوري
|
EP2629777B1
(en)
|
2010-10-22 |
2018-12-19 |
Merck Sharp & Dohme Corp. |
Bicyclic diamines as janus kinase inhibitors
|
BR112013010018B1
(pt)
|
2010-10-25 |
2020-11-10 |
G1 Therapeutics, Inc. |
compostos inibidores de quinase dependente de ciclina e composição farmacêutica
|
JP2012092049A
(ja)
|
2010-10-27 |
2012-05-17 |
Sumitomo Chemical Co Ltd |
有害動物防除組成物及び有害動物の防除方法
|
CA2816022C
(en)
|
2010-10-29 |
2019-09-10 |
Emory University |
Quinazoline derivatives, compositions, and uses related thereto
|
WO2012061337A1
(en)
|
2010-11-02 |
2012-05-10 |
Exelixis, Inc. |
Fgfr2 modulators
|
US20120115903A1
(en)
|
2010-11-10 |
2012-05-10 |
Gruenenthal Gmbh |
Substituted Heteroaromatic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
|
EP2638008B1
(en)
|
2010-11-10 |
2015-07-01 |
Actelion Pharmaceuticals Ltd |
Lactam derivatives useful as orexin receptor antagonists
|
JP2012116825A
(ja)
|
2010-11-11 |
2012-06-21 |
Ehime Univ |
アセンジイミド化合物の製造方法
|
KR101171232B1
(ko)
|
2010-11-15 |
2012-08-06 |
단국대학교 산학협력단 |
스파이로 화합물 및 이를 포함하는 유기전계 발광소자
|
WO2012065297A1
(en)
|
2010-11-16 |
2012-05-24 |
Impact Therapeutics, Inc. |
3-ARYL-6-ARYL-[1,2,4]TRIAZOLO[4,3-a]PYRIDINES AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF
|
CA2816144A1
(en)
|
2010-11-17 |
2012-05-24 |
Amgen Inc. |
Quinoline derivatives as pik3 inhibitors
|
RU2597609C2
(ru)
|
2010-11-18 |
2016-09-10 |
Касина Лайла Иннова Фармасьютикалз Прайвит Лимитед |
Замещенные 4-(селенофен-2(или 3)-иламино)пиримидиновые соединения и способы их применения
|
GB201020179D0
(en)
|
2010-11-29 |
2011-01-12 |
Astex Therapeutics Ltd |
New compounds
|
CA2819373A1
(en)
|
2010-12-09 |
2012-06-14 |
Amgen Inc. |
Bicyclic compounds as pim inhibitors
|
CN104906103B
(zh)
|
2010-12-14 |
2018-05-18 |
电泳有限公司 |
酪蛋白激酶1δ(CK1δ)抑制剂
|
CN103429585B
(zh)
|
2010-12-20 |
2015-07-08 |
默克雪兰诺股份有限公司 |
作为白细胞介素-1受体相关激酶抑制剂的吲唑基三唑衍生物
|
EP2655323B1
(en)
|
2010-12-22 |
2017-12-20 |
Leo Laboratories Limited |
Ingenol-3-acylates iii and ingenol-3-carbamates
|
WO2012088266A2
(en)
|
2010-12-22 |
2012-06-28 |
Incyte Corporation |
Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
|
EP2468258A1
(en)
|
2010-12-22 |
2012-06-27 |
LEK Pharmaceuticals d.d. |
Process for the preparation of a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient
|
CN102603628B
(zh)
|
2010-12-22 |
2016-08-17 |
香港理工大学 |
作为抗癌试剂的喹啉衍生物
|
CA2822312A1
(en)
|
2010-12-22 |
2012-06-28 |
Gunnar Grue-Sorensen |
3-acyl-ingenols ii
|
AU2011349669A1
(en)
|
2010-12-23 |
2013-07-11 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
JP5691508B2
(ja)
|
2010-12-27 |
2015-04-01 |
Jnc株式会社 |
ジイミド化合物ならびにインクジェット用インクおよびその用途
|
KR101466150B1
(ko)
|
2010-12-31 |
2014-11-27 |
제일모직 주식회사 |
유기광전소자용 화합물 및 이를 포함하는 유기광전소자
|
CN103328488B
(zh)
|
2011-01-06 |
2015-12-09 |
吉坤日矿日石能源株式会社 |
酰亚胺化合物及其制造方法、润滑脂用增稠剂和润滑脂组合物
|
US8362023B2
(en)
|
2011-01-19 |
2013-01-29 |
Hoffmann-La Roche Inc. |
Pyrazolo pyrimidines
|
FR2970967B1
(fr)
|
2011-01-27 |
2013-02-15 |
Pf Medicament |
Derives de type azaindazole ou diazaindazole comme medicament
|
EP2487159A1
(en)
|
2011-02-11 |
2012-08-15 |
MSD Oss B.V. |
RorgammaT inhibitors
|
WO2012112965A1
(en)
|
2011-02-18 |
2012-08-23 |
Medivation Technologies, Inc. |
Compounds and methods of treating diabetes
|
WO2012116237A2
(en)
|
2011-02-23 |
2012-08-30 |
Intellikine, Llc |
Heterocyclic compounds and uses thereof
|
TWI532742B
(zh)
|
2011-02-28 |
2016-05-11 |
艾伯維有限公司 |
激酶之三環抑制劑
|
SG192962A1
(en)
|
2011-03-17 |
2013-09-30 |
Novartis Ag |
Fgfr and ligands thereof as biomarkers for breast cancer in hr positive subjects
|
MY161199A
(en)
|
2011-03-23 |
2017-04-14 |
Amgen Inc |
Fused tricyclic dual inhibitors of cdk 4/6 and flt3
|
ITPD20110091A1
(it)
|
2011-03-24 |
2012-09-25 |
Univ Padova |
Inibitori multitirosinchinasi utili per le patologie correlate: modelli farmacoforici, composti identificati tramite questi modelli, metodi per la loro preparazione, la loro formulazione e il loro impiego terapeutico.
|
JP5934778B2
(ja)
|
2011-03-25 |
2016-06-15 |
アッヴィ・インコーポレイテッド |
Trpv1拮抗薬
|
EP2694551A1
(en)
|
2011-04-07 |
2014-02-12 |
Genentech, Inc. |
Anti-fgfr4 antibodies and methods of use
|
FR2974088A1
(fr)
|
2011-04-12 |
2012-10-19 |
Pf Medicament |
Composes pyrazolo[3,4-b]pyridines tri- et tetracycliques comme agent anticancereux
|
US9085626B2
(en)
|
2011-05-16 |
2015-07-21 |
Genentech, Inc. |
FGFR1 agonists and methods of use
|
US9376438B2
(en)
|
2011-05-17 |
2016-06-28 |
Principia Biopharma, Inc. |
Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors
|
WO2012156367A1
(en)
|
2011-05-17 |
2012-11-22 |
Bayer Intellectual Property Gmbh |
Amino-substituted imidazopyridazines as mknk1 kinase inhibitors
|
WO2012158994A1
(en)
|
2011-05-19 |
2012-11-22 |
Novartis Ag |
4-amino-5-fluoro-3- [6- (4 -methylpiperazin- 1 - yl) - 1h - benzimidazol - 2 - yl] - 1h - quinoli n-2-one for use in the treatment of adenoid cystic carcinoma
|
US9730929B2
(en)
|
2011-06-01 |
2017-08-15 |
Bayer Intellectual Property Gmbh |
Substituted aminoimidazopyridazines
|
AR086656A1
(es)
|
2011-06-03 |
2014-01-15 |
Millennium Pharm Inc |
Combinacion de inhibidores de mek e inhibidores selectivos de la quinasa aurora a
|
US9972784B2
(en)
|
2011-06-13 |
2018-05-15 |
Lg Chem, Ltd. |
Compounds and organic electronic device using same
|
JP5944497B2
(ja)
|
2011-06-22 |
2016-07-05 |
バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH |
ヘテロシクリルアミノイミダゾピリダジン
|
US8846656B2
(en)
|
2011-07-22 |
2014-09-30 |
Novartis Ag |
Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulators
|
CN103874700B
(zh)
|
2011-08-12 |
2018-03-30 |
霍夫曼-拉罗奇有限公司 |
吡唑并[3,4‑c]吡啶化合物和使用方法
|
KR102021159B1
(ko)
|
2011-08-12 |
2019-09-11 |
닛산 가가쿠 가부시키가이샤 |
트리시클릭 헤테로시클릭 화합물 및 jak 저해제
|
JP2013049251A
(ja)
|
2011-08-31 |
2013-03-14 |
Fujifilm Corp |
レーザー彫刻用レリーフ印刷版原版、並びに、レリーフ印刷版及びその製版方法
|
WO2013033981A1
(zh)
|
2011-09-06 |
2013-03-14 |
江苏先声药物研究有限公司 |
一类2,7-萘啶衍生物及其制备方法和应用
|
US9345705B2
(en)
|
2011-09-15 |
2016-05-24 |
Merck Sharp & Dohme Corp. |
Compositions and methods for treating cancer
|
US9376435B2
(en)
|
2011-09-23 |
2016-06-28 |
Jawaharlal Nehru Centre For Advanced Scientific Research |
Chromophores for the detection of volatile organic compounds
|
US9320737B2
(en)
|
2011-09-23 |
2016-04-26 |
Bayer Intellectual Property Gmbh |
Substituted imidazopyridazines
|
US20140227321A1
(en)
|
2011-09-30 |
2014-08-14 |
Kineta, Inc. |
Anti-viral compounds
|
UA111382C2
(uk)
|
2011-10-10 |
2016-04-25 |
Оріон Корпорейшн |
Інгібітори протеїнкінази
|
EP2766352B1
(en)
|
2011-10-12 |
2018-06-06 |
University Health Network (UHN) |
Indazole compounds as kinase inhibitors and method of treating cancer with same
|
KR101897044B1
(ko)
|
2011-10-20 |
2018-10-23 |
에스에프씨 주식회사 |
유기금속 화합물 및 이를 포함하는 유기전계발광소자
|
JP2014532647A
(ja)
|
2011-10-28 |
2014-12-08 |
ノバルティス アーゲー |
消化管間質腫瘍を治療する方法
|
WO2013063003A1
(en)
|
2011-10-28 |
2013-05-02 |
Novartis Ag |
Method of treating gastrointestinal stromal tumors
|
WO2013088191A1
(en)
|
2011-12-12 |
2013-06-20 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Antagonist of the fibroblast growth factor receptor 3 (fgfr3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of fgfr3
|
FR2985258A1
(fr)
|
2011-12-28 |
2013-07-05 |
Sanofi Sa |
Composes dimeres agonistes des recepteurs des fgfs (fgfrs), leur procede de preparation et leur application en therapeutique
|
FR2985257B1
(fr)
|
2011-12-28 |
2014-02-14 |
Sanofi Sa |
Composes dimeres agonistes des recepteurs des fgfs (fgfrs), leur procede de preparation et leur application en therapeutique
|
WO2013109027A1
(ko)
|
2012-01-18 |
2013-07-25 |
덕산하이메탈(주) |
화합물, 이를 이용한 유기전기소자 및 그 전자 장치
|
US10026905B2
(en)
|
2012-01-18 |
2018-07-17 |
Duk San Neolux Co., Ltd. |
Compound, organic electric element using the same, and an electronic device thereof
|
SG2014009286A
(en)
|
2012-01-19 |
2014-04-28 |
Taiho Pharmaceutical Co Ltd |
3,5-disubstituted alkynylbenzene compound and salt thereof
|
WO2013124316A1
(en)
|
2012-02-23 |
2013-08-29 |
Bayer Intellectual Property Gmbh |
Substituted benzothienyl-pyrrolotriazines and uses thereof
|
JP2013179181A
(ja)
|
2012-02-28 |
2013-09-09 |
Sumitomo Chemical Co Ltd |
有機光電変換素子
|
PE20141973A1
(es)
|
2012-03-14 |
2014-12-12 |
Lupin Ltd |
Compuestos de heterociclilo como inhibidores de mek
|
IN2014DN08969A
(pt)
|
2012-03-30 |
2015-05-22 |
Novartis Ag |
|
JP5120580B1
(ja)
|
2012-05-14 |
2013-01-16 |
Jsr株式会社 |
液晶配向剤
|
IL289834B1
(en)
|
2012-06-13 |
2024-03-01 |
Incyte Holdings Corp |
Conversion of tricyclic compounds as FGFR inhibitors
|
KR20150036014A
(ko)
|
2012-07-11 |
2015-04-07 |
노파르티스 아게 |
위장 기질 종양을 치료하는 방법
|
WO2014011900A2
(en)
|
2012-07-11 |
2014-01-16 |
Blueprint Medicines |
Inhibitors of the fibroblast growth factor receptor
|
KR20150036245A
(ko)
|
2012-08-02 |
2015-04-07 |
머크 샤프 앤드 돔 코포레이션 |
항당뇨병 트리시클릭 화합물
|
WO2014019186A1
(en)
|
2012-08-02 |
2014-02-06 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
US9388185B2
(en)
|
2012-08-10 |
2016-07-12 |
Incyte Holdings Corporation |
Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
|
KR101985259B1
(ko)
|
2012-08-10 |
2019-06-03 |
제이에스알 가부시끼가이샤 |
액정 배향제 및 화합물
|
WO2014044846A1
(en)
|
2012-09-24 |
2014-03-27 |
Evotec (Uk) Ltd. |
3-(aryl- or heteroaryl-amino)-7-(3,5-dimethoxyphenyl)isoquinoline derivatives as fgfr inhibitors useful for the treatment of proliferative disorders or dysplasia
|
WO2014048878A1
(en)
|
2012-09-26 |
2014-04-03 |
Evotec (Uk) Ltd. |
Phenyl- or pyridyl- pyrrolo[2,3b]pyrazine derivatives useful in the treatment or prevention of proliferative disorders or dysplasia
|
WO2014062454A1
(en)
|
2012-10-15 |
2014-04-24 |
Merck Sharp & Dohme Corp. |
Compositions and methods for treating cancer
|
KR102000211B1
(ko)
|
2012-10-29 |
2019-09-30 |
삼성디스플레이 주식회사 |
유기금속 화합물 및 이를 포함한 유기 발광 소자
|
SI2925888T1
(en)
|
2012-11-28 |
2018-02-28 |
Merck Sharp & Dohme Corp. |
Compounds and methods for the treatment of cancer
|
US20140148548A1
(en)
|
2012-11-28 |
2014-05-29 |
Central Glass Company, Limited |
Fluorine-Containing Polymerizable Monomer And Polymer Compound Using Same
|
CN104968664A
(zh)
|
2012-12-12 |
2015-10-07 |
山东亨利医药科技有限责任公司 |
作为酪氨酸激酶抑制剂的并环化合物
|
US9266892B2
(en)
|
2012-12-19 |
2016-02-23 |
Incyte Holdings Corporation |
Fused pyrazoles as FGFR inhibitors
|
TWI629266B
(zh)
|
2012-12-28 |
2018-07-11 |
藍印藥品公司 |
纖維母細胞生長因子受體之抑制劑
|
WO2014105849A1
(en)
|
2012-12-28 |
2014-07-03 |
Xoma (Us) Llc |
Antibodies specific for fgfr4 and methods of use
|
KR102030587B1
(ko)
|
2013-01-09 |
2019-10-10 |
에스에프씨주식회사 |
두 개의 나프틸기를 포함하는 비대칭 안트라센 유도체 및 이를 포함하는 유기 발광 소자
|
EP2945623B1
(en)
|
2013-01-15 |
2018-09-05 |
Suzhou Kintor Pharmaceuticals, Inc. |
Hedgehog pathway signaling inhibitors and therapeutic applications thereof
|
CN103588771B
(zh)
|
2013-01-15 |
2016-01-27 |
苏州云轩医药科技有限公司 |
具有刺猬通路拮抗剂活性的嘧啶类抗肿瘤化合物
|
KR101456626B1
(ko)
|
2013-02-01 |
2014-11-03 |
대영이앤비 주식회사 |
냉장고 부압 방지 장치
|
WO2014136972A1
(ja)
|
2013-03-07 |
2014-09-12 |
国立大学法人九州大学 |
超分子複合体、発光体、および有機化合物検出用のセンサー素子
|
WO2014138485A1
(en)
|
2013-03-08 |
2014-09-12 |
Irm Llc |
Ex vivo production of platelets from hematopoietic stem cells and the product thereof
|
US9498532B2
(en)
|
2013-03-13 |
2016-11-22 |
Novartis Ag |
Antibody drug conjugates
|
US9771327B2
(en)
|
2013-03-13 |
2017-09-26 |
Flatley Discovery Lab, Llc |
Compounds and methods for the treatment of cystic fibrosis
|
AU2014230745A1
(en)
|
2013-03-14 |
2015-09-03 |
AbbVie Deutschland GmbH & Co. KG |
Novel inhibitor compounds of phosphodiesterase type 10A
|
AU2014228746B2
(en)
|
2013-03-15 |
2018-08-30 |
Celgene Car Llc |
Heteroaryl compounds and uses thereof
|
EP3943087A1
(en)
|
2013-03-15 |
2022-01-26 |
Celgene CAR LLC |
Heteroaryl compounds and uses thereof
|
TWI647220B
(zh)
|
2013-03-15 |
2019-01-11 |
美商西建卡爾有限責任公司 |
雜芳基化合物及其用途
|
EP2970231A1
(en)
|
2013-03-15 |
2016-01-20 |
Blueprint Medicines Corporation |
Piperazine derivatives and their use as kit modulators
|
TWI628176B
(zh)
|
2013-04-04 |
2018-07-01 |
奧利安公司 |
蛋白質激酶抑制劑
|
KR101573611B1
(ko)
|
2013-04-17 |
2015-12-01 |
주식회사 엘지화학 |
플러렌 유도체, 이를 이용한 유기 태양 전지 및 이의 제조 방법
|
SG10201708520YA
(en)
|
2013-04-19 |
2017-12-28 |
Incyte Corp |
Bicyclic heterocycles as fgfr inhibitors
|
SG11201508231UA
(en)
|
2013-04-19 |
2015-11-27 |
Covagen Ag |
Novel bispecific binding molecules with antitumoral activity
|
GB201307577D0
(en)
|
2013-04-26 |
2013-06-12 |
Astex Therapeutics Ltd |
New compounds
|
US9630963B2
(en)
|
2013-05-09 |
2017-04-25 |
Principia Biopharma, Inc. |
Quinolone derivatives as fibroblast growth factor inhibitors
|
MX2015017201A
(es)
|
2013-06-14 |
2016-04-06 |
Sanofi Sa |
Derivados de pirazolopiridina para uso en el tratamiento del cancer de vejiga.
|
WO2014206344A1
(en)
|
2013-06-28 |
2014-12-31 |
Beigene, Ltd. |
Fused tricyclic amide compounds as multiple kinase inhibitors
|
JP6380861B2
(ja)
|
2013-06-28 |
2018-08-29 |
ベイジーン リミテッド |
Rafキナ−ゼおよび/またはRafキナ−ゼの二量体阻害剤としての縮合三環式ウレア系化合物
|
JP6677637B2
(ja)
|
2013-07-02 |
2020-04-08 |
シンジェンタ パーティシペーションズ アーゲー |
有害生物防除的に活性な、硫黄含有置換基を有する二環式または三環式複素環
|
AU2014287209B2
(en)
|
2013-07-09 |
2019-01-24 |
Dana-Farber Cancer Institute, Inc. |
Kinase inhibitors for the treatment of disease
|
JP6018547B2
(ja)
|
2013-07-09 |
2016-11-02 |
大成ロテック株式会社 |
舗装機械
|
SG11201600062RA
(en)
|
2013-07-11 |
2016-02-26 |
Acea Biosciences Inc |
Pyrimidine derivatives as kinase inhibitors
|
TW201605452A
(zh)
|
2013-08-28 |
2016-02-16 |
安斯泰來製藥股份有限公司 |
以嘧啶化合物作爲有效成分之醫藥組成物
|
DK3057943T3
(en)
|
2013-10-18 |
2018-07-30 |
Eisai R&D Man Co Ltd |
PYRIMIDINE-FGFR4 INHIBITORS
|
HUE059037T2
(hu)
|
2013-10-25 |
2022-10-28 |
Blueprint Medicines Corp |
Fibroblaszt növekedési faktor receptor gátlók
|
US9266883B2
(en)
|
2013-10-25 |
2016-02-23 |
Novartis Ag |
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
|
FR3012330B1
(fr)
|
2013-10-29 |
2015-10-23 |
Oreal |
Composition biphase comprenant un ester d'acide gras et de sucre ou un alkylpolyglucoside liquide, de hlb < 8, et un alcane ramifie en c8-c18
|
WO2015066452A2
(en)
|
2013-11-01 |
2015-05-07 |
Foundation Medicine, Inc. |
Methods of treating pediatric cancers
|
US9695165B2
(en)
|
2014-01-15 |
2017-07-04 |
Blueprint Medicines Corporation |
Inhibitors of the fibroblast growth factor receptor
|
BR112017003312B1
(pt)
|
2014-08-19 |
2023-05-02 |
Shanghai Haihe Pharmaceutical Co., Ltd. |
Compostos de indazol como inibidores de fgfr quinase, preparação e uso dos mesmos
|
CN104262330B
(zh)
|
2014-08-27 |
2016-09-14 |
广东东阳光药业有限公司 |
一种脲取代联苯类化合物及其组合物及用途
|
AU2015316796A1
(en)
|
2014-09-19 |
2017-03-30 |
Bayer Pharma Aktiengesellschaft |
Benzyl substituted indazoles as Bub1 inhibitors
|
WO2016064960A1
(en)
|
2014-10-22 |
2016-04-28 |
Incyte Corporation |
Bicyclic heterocycles as fgfr4 inhibitors
|
US10851105B2
(en)
|
2014-10-22 |
2020-12-01 |
Incyte Corporation |
Bicyclic heterocycles as FGFR4 inhibitors
|
SG11201706729SA
(en)
|
2015-02-20 |
2017-09-28 |
Univ Oregon Health & Science |
Derivatives of sobetirome
|
US9580423B2
(en)
|
2015-02-20 |
2017-02-28 |
Incyte Corporation |
Bicyclic heterocycles as FGFR4 inhibitors
|
MA41551A
(fr)
|
2015-02-20 |
2017-12-26 |
Incyte Corp |
Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
|
MX2017010673A
(es)
|
2015-02-20 |
2018-03-21 |
Incyte Corp |
Heterociclos biciclicos como inhibidores de receptores del factor de crecimiento fibroblastico (fgfr).
|
US10363220B2
(en)
|
2015-06-03 |
2019-07-30 |
Triastek, Inc. |
Compartmented pharmaceutical dosage forms
|
GB201512369D0
(en)
|
2015-07-15 |
2015-08-19 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
|
CA2992267C
(en)
|
2015-07-15 |
2020-07-21 |
Cabot Corporation |
Methods of making an elastomer composite reinforced with silica and products containing same
|
JP6761821B2
(ja)
|
2015-07-15 |
2020-09-30 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
代謝性グルタミン酸受容体モジュレーターとしてのエチニル誘導体
|
CR20180029A
(es)
|
2015-07-15 |
2018-06-05 |
Protagonist Therapeutics Inc |
Inhibidores peotídicos del receptor de interleucina 23 y su uso para tratar enfermedades inflamatorias
|
PL3328419T3
(pl)
|
2015-07-30 |
2021-12-27 |
Macrogenics, Inc. |
Cząsteczki wiążące pd-1 i sposoby ich zastosowania
|
WO2017028314A1
(en)
|
2015-08-20 |
2017-02-23 |
Changzhou Jiekai Pharmatech Co., Ltd. |
Pyrazolo fused heterocyclic compounds as erk inhibitors
|
EP3356349A1
(en)
|
2015-09-28 |
2018-08-08 |
Araxes Pharma LLC |
Inhibitors of kras g12c mutant proteins
|
TW201718581A
(zh)
|
2015-10-19 |
2017-06-01 |
英塞特公司 |
作為免疫調節劑之雜環化合物
|
WO2017070708A1
(en)
|
2015-10-23 |
2017-04-27 |
Array Biopharma, Inc. |
2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2h)-one compounds as inhibitors of fgfr tyrosine kinases
|
TWI763641B
(zh)
|
2015-11-19 |
2022-05-11 |
美商英塞特公司 |
作為免疫調節劑之雜環化合物
|
MA44075A
(fr)
|
2015-12-17 |
2021-05-19 |
Incyte Corp |
Dérivés de n-phényl-pyridine-2-carboxamide et leur utilisation en tant que modulateurs des interactions protéine/protéine pd-1/pd-l1
|
TWI767896B
(zh)
|
2015-12-22 |
2022-06-21 |
美商英塞特公司 |
作為免疫調節劑之雜環化合物
|
US20170320875A1
(en)
|
2016-05-06 |
2017-11-09 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
EP3464279B1
(en)
|
2016-05-26 |
2021-11-24 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
AU2017281285C1
(en)
|
2016-06-20 |
2022-05-12 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
US20180016260A1
(en)
|
2016-07-14 |
2018-01-18 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
MA46045A
(fr)
|
2016-08-29 |
2021-04-28 |
Incyte Corp |
Composés hétérocycliques utilisés comme immunomodulateurs
|
WO2018041091A1
(en)
|
2016-08-30 |
2018-03-08 |
Sunshine Lake Pharma Co., Ltd. |
Inhibitors of influenza virus replication, application methods and uses thereof
|
US20180072718A1
(en)
|
2016-09-09 |
2018-03-15 |
Incyte Corporation |
Pyrazolopyridine compounds and uses thereof
|
WO2018067512A1
(en)
|
2016-10-05 |
2018-04-12 |
Kalyra Pharmaceuticals, Inc. |
Spirocyclic compounds
|
KR101755556B1
(ko)
|
2016-11-18 |
2017-07-07 |
주식회사 케마스 |
육산화사비소의 결정다형을 포함하는 뇌암 예방 또는 치료용 약학 조성물 및 이의 제조방법
|
KR101834366B1
(ko)
|
2016-11-21 |
2018-03-05 |
주식회사 케마스 |
육산화사비소의 결정다형을 포함하는 유방암 예방 또는 치료용 약학 조성물 및 이의 제조방법
|
KR101844049B1
(ko)
|
2016-12-05 |
2018-03-30 |
주식회사 케마스 |
육산화사비소의 결정다형을 포함하는 간암 예방 또는 치료용 약학 조성물
|
KR101844050B1
(ko)
|
2016-12-09 |
2018-05-14 |
주식회사 케마스 |
육산화사비소의 결정다형을 포함하는 암 예방 또는 치료용 약학 조성물
|
MA47120A
(fr)
|
2016-12-22 |
2021-04-28 |
Incyte Corp |
Dérivés pyridine utilisés en tant qu'immunomodulateurs
|
SG10202106743QA
(en)
|
2016-12-22 |
2021-08-30 |
Incyte Corp |
Tetrahydro imidazo[4,5-c]pyridine derivatives as pd-l1 internalization inducers
|
WO2018119263A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds derivatives as pd-l1 internalization inducers
|
US20180179202A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
TWI808955B
(zh)
|
2016-12-22 |
2023-07-21 |
美商英塞特公司 |
作為免疫調節劑之雜環化合物
|
US20180179201A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
AR111960A1
(es)
|
2017-05-26 |
2019-09-04 |
Incyte Corp |
Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
|
WO2018234354A1
(en)
|
2017-06-20 |
2018-12-27 |
Grünenthal GmbH |
NOVEL SUBSTITUTED 3-INDOLE AND 3-INDAZOLE COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS
|
EP3672973A4
(en)
|
2017-08-22 |
2021-05-26 |
JS Innopharm (Shanghai) Ltd. |
HETEROCYCLIC COMPOUNDS USED AS KINASE INHIBITORS, COMPOSITIONS INCLUDING THE HETEROCYCLIC COMPOUND, AND METHODS OF USE THEREOF
|
AU2018352695A1
(en)
|
2017-10-19 |
2020-05-28 |
Effector Therapeutics, Inc. |
Benzimidazole-indole inhibitors of Mnk1 and Mnk2
|
CN111433200B
(zh)
|
2017-12-02 |
2024-03-22 |
加拉帕戈斯股份有限公司 |
用于治疗疾病的化合物及其药物组合物
|
ES2940750T3
(es)
|
2018-03-30 |
2023-05-11 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
CR20200590A
(es)
|
2018-05-04 |
2021-04-26 |
Incyte Corp |
Formas sólidas de un inhibidor de fgfr y procesos para prepararlas
|
US11174257B2
(en)
|
2018-05-04 |
2021-11-16 |
Incyte Corporation |
Salts of an FGFR inhibitor
|
PE20211918A1
(es)
|
2018-05-11 |
2021-09-28 |
Incyte Corp |
Derivados de tetrahidro-imidazo[4,5-c]piridin como inmunomoduladores de pd-l1
|
AU2019321434A1
(en)
|
2018-08-14 |
2021-03-04 |
Osteoqc Inc |
Pyrrolo - dipyridine compounds
|
DK3846904T3
(da)
|
2018-09-07 |
2023-08-21 |
Merck Patent Gmbh |
5-morpholin-4-yl-pyrazolo[4,3-b]pyridinderivater
|
CN113490666A
(zh)
|
2018-12-19 |
2021-10-08 |
奥瑞生物药品公司 |
作为fgfr酪氨酸激酶的抑制剂的取代的吡唑并[1,5-a]吡啶化合物
|
WO2020131674A1
(en)
|
2018-12-19 |
2020-06-25 |
Array Biopharma Inc. |
7-((3,5-dimethoxyphenyl)amino)quinoxaline derivatives as fgfr inhibitors for treating cancer
|
WO2021007269A1
(en)
|
2019-07-09 |
2021-01-14 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
WO2021067374A1
(en)
|
2019-10-01 |
2021-04-08 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|